Roy Burstein1, Nathaniel J Henry1, Michael L Collison1, Laurie B Marczak1, Amber Sligar1, Stefanie Watson1, Neal Marquez1, Mahdieh Abbasalizad-Farhangi2, Masoumeh Abbasi3, Foad Abd-Allah4, Amir Abdoli5, Mohammad Abdollahi6, Ibrahim Abdollahpour7,8, Rizwan Suliankatchi Abdulkader9, Michael R M Abrigo10, Dilaram Acharya11,12, Oladimeji M Adebayo13, Victor Adekanmbi14, Davoud Adham15, Mahdi Afshari16, Mohammad Aghaali17, Keivan Ahmadi18, Mehdi Ahmadi19, Ehsan Ahmadpour20, Rushdia Ahmed21,22, Chalachew Genet Akal23, Joshua O Akinyemi24, Fares Alahdab25, Noore Alam26, Genet Melak Alamene27, Kefyalew Addis Alene28,29, Mehran Alijanzadeh30, Cyrus Alinia31, Vahid Alipour32,33, Syed Mohamed Aljunid34,35, Mohammed J Almalki36,37, Hesham M Al-Mekhlafi38,39, Khalid Altirkawi40, Nelson Alvis-Guzman41,42, Adeladza Kofi Amegah43, Saeed Amini44, Arianna Maever Loreche Amit45,46, Zohreh Anbari44, Sofia Androudi47, Mina Anjomshoa48, Fereshteh Ansari49, Carl Abelardo T Antonio50,51, Jalal Arabloo33, Zohreh Arefi52, Olatunde Aremu53, Bahram Armoon54,55, Amit Arora56,57, Al Artaman58, Anvar Asadi59, Mehran Asadi-Aliabadi60, Amir Ashraf-Ganjouei7,61, Reza Assadi62, Bahar Ataeinia63, Sachin R Atre64,65, Beatriz Paulina Ayala Quintanilla66,67, Martin Amogre Ayanore68, Samad Azari33, Ebrahim Babaee60, Arefeh Babazadeh69, Alaa Badawi70,71, Soghra Bagheri3, Mojtaba Bagherzadeh72, Nafiseh Baheiraei73,74, Abbas Balouchi75, Aleksandra Barac76,77, Quique Bassat78,79, Bernhard T Baune80, Mohsen Bayati81, Neeraj Bedi37,82, Ettore Beghi83, Masoud Behzadifar84, Meysam Behzadifar85, Yared Belete Belay86, Brent Bell1, Michelle L Bell87, Dessalegn Ajema Berbada88, Robert S Bernstein89,90, Natalia V Bhattacharjee1, Suraj Bhattarai91,92, Zulfiqar A Bhutta93,94, Ali Bijani95, Somayeh Bohlouli96, Nicholas J K Breitborde97,98, Gabrielle Britton99,100, Annie J Browne101, Sharath Burugina Nagaraja102, Reinhard Busse103, Zahid A Butt104,105, Josip Car106,107, Rosario Cárdenas108, Carlos A Castañeda-Orjuela109,110, Ester Cerin111,112, Wagaye Fentahun Chanie113, Pranab Chatterjee114, Dinh-Toi Chu115, Cyrus Cooper116,117, Vera M Costa118, Koustuv Dalal119,120, Lalit Dandona1,121, Rakhi Dandona1,121, Farah Daoud1, Ahmad Daryani122, Rajat Das Gupta21, Ian Davis1, Nicole Davis Weaver1, Dragos Virgil Davitoiu123,124, Jan-Walter De Neve125, Feleke Mekonnen Demeke126, Gebre Teklemariam Demoz127,128, Kebede Deribe129,130, Rupak Desai131, Aniruddha Deshpande1, Hanna Demelash Desyibelew132, Sagnik Dey133, Samath Dhamminda Dharmaratne1,134, Meghnath Dhimal135, Daniel Diaz136,137, Leila Doshmangir138, Andre R Duraes139,140, Laura Dwyer-Lindgren1,141, Lucas Earl1, Roya Ebrahimi142, Soheil Ebrahimpour69, Andem Effiong143, Aziz Eftekhari144,145, Elham Ehsani-Chimeh146, Iman El Sayed147, Maysaa El Sayed Zaki148, Maha El Tantawi149,150, Ziad El-Khatib151, Mohammad Hassan Emamian152, Shymaa Enany153, Sharareh Eskandarieh7, Oghenowede Eyawo154,155, Maha Ezalarab1, Mahbobeh Faramarzi156, Mohammad Fareed157, Roghiyeh Faridnia158, Andre Faro159, Ali Akbar Fazaeli160, Mehdi Fazlzadeh161,162, Netsanet Fentahun163, Seyed-Mohammad Fereshtehnejad164,165, João C Fernandes166, Irina Filip167,168, Florian Fischer169, Nataliya A Foigt170, Masoud Foroutan171, Joel Msafiri Francis172, Takeshi Fukumoto173,174, Nancy Fullman1, Silvano Gallus175, Destallem Gebremedhin Gebre176,177, Tsegaye Tewelde Gebrehiwot178, Gebreamlak Gebremedhn Gebremeskel179,180, Bradford D Gessner181,182, Birhanu Geta183, Peter W Gething101, Reza Ghadimi184, Keyghobad Ghadiri3, Mahsa Ghajarzadeh185, Ahmad Ghashghaee186, Paramjit Singh Gill187, Tiffany K Gill188, Nick Golding189, Nelson G M Gomes190,191, Philimon N Gona192, Sameer Vali Gopalani193,194, Giuseppe Gorini195, Bárbara Niegia Garcia Goulart196, Nicholas Graetz1, Felix Greaves197,198, Manfred S Green199, Yuming Guo200,201, Arvin Haj-Mirzaian202,203, Arya Haj-Mirzaian202,204, Brian James Hall205, Samer Hamidi206, Hamidreza Haririan207, Josep Maria Haro208,209, Milad Hasankhani210, Edris Hasanpoor211, Amir Hasanzadeh212,213, Hadi Hassankhani214,215, Hamid Yimam Hassen216,217, Mohamed I Hegazy4, Delia Hendrie218, Fatemeh Heydarpour219, Thomas R Hird200,220, Chi Linh Hoang221, Gillian Hollerich1, Enayatollah Homaie Rad222,223, Mojtaba Hoseini-Ghahfarokhi224, Naznin Hossain22,225, Mostafa Hosseini226, Mehdi Hosseinzadeh33,227, Mihaela Hostiuc123,228, Sorin Hostiuc229,230, Mowafa Househ231,232, Mohamed Hsairi233, Olayinka Stephen Ilesanmi234, Mohammad Hasan Imani-Nasab235, Usman Iqbal236, Seyed Sina Naghibi Irvani237, Nazrul Islam238,239, Sheikh Mohammed Shariful Islam240,241, Mikk Jürisson242, Nader Jafari Balalami243, Amir Jalali244, Javad Javidnia245, Achala Upendra Jayatilleke246,247, Ensiyeh Jenabi248, John S Ji249, Yash B Jobanputra250, Kimberly Johnson1, Jost B Jonas251,252, Zahra Jorjoran Shushtari253, Jacek Jerzy Jozwiak254,255, Ali Kabir256, Amaha Kahsay257, Hamed Kalani258,259, Rohollah Kalhor260, Manoochehr Karami261, Surendra Karki262,263, Amir Kasaeian264,265, Nicholas J Kassebaum1,266, Peter Njenga Keiyoro267, Grant Rodgers Kemp1,268, Roghayeh Khabiri269,270, Yousef Saleh Khader271, Morteza Abdullatif Khafaie272, Ejaz Ahmad Khan273, Junaid Khan274, Muhammad Shahzeb Khan275,276, Young-Ho Khang277,278, Khaled Khatab279,280, Amir Khater281, Mona M Khater282, Alireza Khatony3, Mohammad Khazaei283, Salman Khazaei261, Maryam Khazaei-Pool284, Jagdish Khubchandani285, Neda Kianipour3,286, Yun Jin Kim287, Ruth W Kimokoti288, Damaris K Kinyoki1,141, Adnan Kisa289,290, Sezer Kisa291, Tufa Kolola292, Soewarta Kosen293, Parvaiz A Koul294, Ai Koyanagi79,295, Moritz U G Kraemer296,297, Kewal Krishan298, Kris J Krohn1, Nuworza Kugbey299,300, G Anil Kumar121, Manasi Kumar301,302, Pushpendra Kumar303, Desmond Kuupiel304,305, Ben Lacey306,307, Sheetal D Lad308, Faris Hasan Lami309, Anders O Larsson310,311, Paul H Lee312, Mostafa Leili283, Aubrey J Levine1, Shanshan Li200, Lee-Ling Lim313,314, Stefan Listl315,316, Joshua Longbottom317, Jaifred Christian F Lopez45,318, Stefan Lorkowski319,320, Sameh Magdeldin321,322, Hassan Magdy Abd El Razek323, Muhammed Magdy Abd El Razek324, Azeem Majeed197, Afshin Maleki142, Reza Malekzadeh325,326, Deborah Carvalho Malta327, Abdullah A Mamun328, Navid Manafi329,330, Ana-Laura Manda331, Morteza Mansourian332, Francisco Rogerlândio Martins-Melo333, Anthony Masaka334, Benjamin Ballard Massenburg335, Pallab K Maulik336,337, Benjamin K Mayala1, Mohsen Mazidi338, Martin McKee339, Ravi Mehrotra340, Kala M Mehta341, Gebrekiros Gebremichael Meles88, Walter Mendoza342, Ritesh G Menezes343, Atte Meretoja344,345, Tuomo J Meretoja346,347, Tomislav Mestrovic348,349, Ted R Miller218,350, Molly K Miller-Petrie1, Edward J Mills351, George J Milne352, G K Mini353, Seyed Mostafa Mir354,355, Hamed Mirjalali356, Erkin M Mirrakhimov357,358, Efat Mohamadi359, Dara K Mohammad360,361, Aso Mohammad Darwesh362, Naser Mohammad Gholi Mezerji363, Ammas Siraj Mohammed364, Shafiu Mohammed365,366, Ali H Mokdad1,141, Mariam Molokhia367, Lorenzo Monasta368, Yoshan Moodley304, Mahmood Moosazadeh369, Ghobad Moradi370,371, Masoud Moradi3,59, Yousef Moradi372, Maziar Moradi-Lakeh60, Mehdi Moradinazar59, Paula Moraga373, Lidia Morawska374, Abbas Mosapour354,375, Seyyed Meysam Mousavi376, Ulrich Otto Mueller377,378, Atalay Goshu Muluneh379, Ghulam Mustafa380,381, Behnam Nabavizadeh382, Mehdi Naderi383, Ahamarshan Jayaraman Nagarajan384,385, Azin Nahvijou386, Farid Najafi387, Vinay Nangia388, Duduzile Edith Ndwandwe389, Nahid Neamati354, Ionut Negoi390,391, Ruxandra Irina Negoi392,393, Josephine W Ngunjiri394, Huong Lan Thi Nguyen395, Long Hoang Nguyen396, Son Hoang Nguyen396, Katie R Nielsen397,398, Dina Nur Anggraini Ningrum399,400, Yirga Legesse Nirayo401, Molly R Nixon1, Chukwudi A Nnaji389,402, Marzieh Nojomi60,403, Mehdi Noroozi404, Shirin Nosratnejad405, Jean Jacques Noubiap406, Soraya Nouraei Motlagh235, Richard Ofori-Asenso407,408, Felix Akpojene Ogbo409, Kelechi E Oladimeji304,410, Andrew T Olagunju411,412, Meysam Olfatifar413, Solomon Olum414,415, Bolajoko Olubukunola Olusanya416, Mojisola Morenike Oluwasanu417, Obinna E Onwujekwe418, Eyal Oren419,420, Doris D V Ortega-Altamirano421, Alberto Ortiz422,423, Osayomwanbo Osarenotor424, Frank B Osei425,426, Aaron E Osgood-Zimmerman1, Stanislav S Otstavnov427,428, Mayowa Ojo Owolabi429, Mahesh P A430, Abdol Sattar Pagheh122, Smita Pakhale431, Songhomitra Panda-Jonas432, Animika Pandey121, Eun-Kee Park433, Hadi Parsian354, Tahereh Pashaei142, Sangram Kishor Patel434,435, Veincent Christian Filipino Pepito436, Alexandre Pereira437,438, Samantha Perkins1, Brandon V Pickering1, Thomas Pilgrim439, Majid Pirestani440, Bakhtiar Piroozi371, Meghdad Pirsaheb3, Oleguer Plana-Ripoll441, Hadi Pourjafar442,443, Parul Puri303, Mostafa Qorbani444, Hedley Quintana100, Mohammad Rabiee445, Navid Rabiee72, Amir Radfar446,447, Alireza Rafiei448,449, Fakher Rahim450,451, Zohreh Rahimi452, Vafa Rahimi-Movaghar453, Shadi Rahimzadeh63, Fatemeh Rajati454, Sree Bhushan Raju455, Azra Ramezankhani456,457, Chhabi Lal Ranabhat458,459, Davide Rasella460,461, Vahid Rashedi462, Lal Rawal56,463, Robert C Reiner1,141, Andre M N Renzaho464, Satar Rezaei465, Aziz Rezapour33, Seyed Mohammad Riahi466,467, Ana Isabel Ribeiro468, Leonardo Roever469, Elias Merdassa Roro470,471, Max Roser472, Gholamreza Roshandel325,473, Daem Roshani474, Ali Rostami475, Enrico Rubagotti476,477, Salvatore Rubino478, Siamak Sabour466, Nafis Sadat1, Ehsan Sadeghi59, Reza Saeedi479, Yahya Safari3, Roya Safari-Faramani480, Mahdi Safdarian453,481, Amirhossein Sahebkar482,483, Mohammad Reza Salahshoor484, Nasir Salam485, Payman Salamati453,486, Farkhonde Salehi487, Saleh Salehi Zahabi488,489, Yahya Salimi387, Hamideh Salimzadeh325, Joshua A Salomon490, Evanson Zondani Sambala389, Abdallah M Samy491, Milena M Santric Milicevic492, Bruno Piassi Sao Jose493, Sivan Yegnanarayana Iyer Saraswathy494,495, Rodrigo Sarmiento-Suárez496, Benn Sartorius141,497, Brijesh Sathian498,499, Sonia Saxena500, Alyssa N Sbarra1, Lauren E Schaeffer1, David C Schwebel501, Sadaf G Sepanlou325,326, Seyedmojtaba Seyedmousavi502,503, Faramarz Shaahmadi504, Masood Ali Shaikh505, Mehran Shams-Beyranvand63,506, Amir Shamshirian507, Morteza Shamsizadeh508, Kiomars Sharafi3, Mehdi Sharif509,510, Mahdi Sharif-Alhoseini453, Hamid Sharifi511, Jayendra Sharma512, Rajesh Sharma513, Aziz Sheikh514,515, Chloe Shields1, Mika Shigematsu516, Rahman Shiri517, Ivy Shiue518, Kerem Shuval199, Tariq J Siddiqi276, João Pedro Silva118, Jasvinder A Singh519,520, Dhirendra Narain Sinha521,522, Malede Mequanent Sisay379,523, Solomon Sisay524, Karen Sliwa406, David L Smith1,141, Ranjani Somayaji525,526, Moslem Soofi527, Joan B Soriano528,529, Chandrashekhar T Sreeramareddy530, Agus Sudaryanto531, Mu'awiyyah Babale Sufiyan532, Bryan L Sykes533, P N Sylaja534, Rafael Tabarés-Seisdedos535,536, Karen M Tabb537, Takahiro Tabuchi538, Nuno Taveira539,540, Mohamad-Hani Temsah541,542, Abdullah Sulieman Terkawi543,544, Zemenu Tadesse Tessema379, Kavumpurathu Raman Thankappan545, Sathish Thirunavukkarasu546, Quyen G To547, Marcos Roberto Tovani-Palone548, Bach Xuan Tran549, Khanh Bao Tran550,551, Irfan Ullah552,553, Muhammad Shariq Usman276, Olalekan A Uthman554, Amir Vahedian-Azimi555,556, Pascual R Valdez557,558, Job F M van Boven559,560, Tommi Juhani Vasankari561, Yasser Vasseghian465, Yousef Veisani562, Narayanaswamy Venketasubramanian563,564, Francesco S Violante565,566, Sergey Konstantinovitch Vladimirov567,568, Vasily Vlassov569, Theo Vos1,141, Giang Thu Vu221, Isidora S Vujcic77, Yasir Waheed570, Jon Wakefield571, Haidong Wang1,141, Yafeng Wang572, Yuan-Pang Wang573, Joseph L Ward574, Robert G Weintraub575,576, Kidu Gidey Weldegwergs401, Girmay Teklay Weldesamuel577, Ronny Westerman578, Charles Shey Wiysonge579,580, Dawit Zewdu Wondafrash581,582, Lauren Woyczynski1, Ai-Min Wu583, Gelin Xu584, Abbas Yadegar356, Tomohide Yamada585, Vahid Yazdi-Feyzabadi586,587, Christopher Sabo Yilgwan588,589, Paul Yip590,591, Naohiro Yonemoto592, Javad Yoosefi Lebni332, Mustafa Z Younis593,594, Mahmoud Yousefifard595, Hebat-Allah Salah A Yousof596, Chuanhua Yu572,597, Hasan Yusefzadeh598, Erfan Zabeh599,600, Telma Zahirian Moghadam33,601, Sojib Bin Zaman602,603, Mohammad Zamani604, Hamed Zandian601,605, Alireza Zangeneh527, Taddese Alemu Zerfu606,607, Yunquan Zhang608,609, Arash Ziapour332, Sanjay Zodpey610, Christopher J L Murray1,141, Simon I Hay611,612. 1. Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA. 2. Department of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran. 3. Kermanshah University of Medical Sciences, Kermanshah, Iran. 4. Department of Neurology, Cairo University, Cairo, Egypt. 5. Department of Parasitology and Mycology, Jahrom University of Medical Sciences, Jahrom, Iran. 6. The Institute of Pharmaceutical Sciences, Tehran University of Medical Sciences, Tehran, Iran. 7. Multiple Sclerosis Research Center, Tehran University of Medical Sciences, Tehran, Iran. 8. Department of Epidemiology, Arak University of Medical Sciences, Arak, Iran. 9. Department of Public Health, Ministry of Health, Riyadh, Saudi Arabia. 10. Research Department, Philippine Institute for Development Studies, Quezon City, The Philippines. 11. Department of Preventive Medicine, Dongguk University, Gyeongju, South Korea. 12. Department of Community Medicine, Kathmandu University, Devdaha, Nepal. 13. College of Medicine, University College Hospital, Ibadan, Nigeria. 14. School of Medicine, Cardiff University, Cardiff, UK. 15. School of Health, Ardabil University of Medical Science, Ardabil, Iran. 16. Department of Community Medicine, Zabol University of Medical Sciences, Zabol, Iran. 17. Department of Epidemiology and Biostatistics, Qom University of Medical Sciences, Qom, Iran. 18. School of Pharmacy, University of Lincoln, Lincoln, UK. 19. Environmental Technologies Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. 20. Department of Parasitology and Mycology, Tabriz University of Medical Sciences, Tabriz, Iran. 21. James P. Grant School of Public Health, Brac University, Dhaka, Bangladesh. 22. Health Systems and Population Studies Division, International Centre for Diarrhoeal Disease Research Bangladesh, Dhaka, Bangladesh. 23. Department of Medical Laboratory Science, Bahir Dar University, Bahir Dar, Ethiopia. 24. Epidemiology and Medical Statistics, University of Ibadan, Ibadan, Nigeria. 25. Evidence Based Practice Center, Mayo Clinic Foundation for Medical Education and Research, Rochester, MN, USA. 26. Prevention Division, Queensland Health, Herston, Queensland, Australia. 27. School of Health Sciences, Madda Walabu University, Bale Goba, Ethiopia. 28. Institute of Public Health, University of Gondar, Gondar, Ethiopia. 29. Research School of Population Health, Australian National University, Canberra, Australian Capital Territory, Australia. 30. Qazvin University of Medical Sciences, Qazvin, Iran. 31. Department of Health Care Management and Economics, Urmia University of Medical Science, Urmia, Iran. 32. Health Economics Department, Iran University of Medical Sciences, Tehran, Iran. 33. Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran. 34. Department of Health Policy and Management, Kuwait University, Safat, Kuwait. 35. International Centre for Casemix and Clinical Coding, National University of Malaysia, Bandar Tun Razak, Malaysia. 36. Faculty of Public Health and Tropical Medicine, Jazan University, Jazan, Saudi Arabia. 37. Jazan University, Jazan, Saudi Arabia. 38. Medical Research Center, Jazan University, Jazan, Saudi Arabia. 39. Department of Medical Parasitology, Sana'a University, Sana'a, Yemen. 40. King Saud University, Riyadh, Saudi Arabia. 41. Research Group in Health Economics, Universidad de Cartagena, Cartagena, Colombia. 42. Research Group in Hospital Management and Health Policies, Universidad de la Costa, Barranquilla, Colombia. 43. Biomedical Science, University of Cape Coast, Cape Coast, Ghana. 44. Health Services Management Department, Arak University of Medical Sciences, Arak, Iran. 45. Department of Epidemiology and Biostatistics, University of the Philippines Manila, Manila, The Philippines. 46. Online Programs for Applied Learning, Johns Hopkins University, Baltimore, MD, USA. 47. Department of Medicine, University of Thessaly, Volos, Greece. 48. Social Determinants of Health Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. 49. Research Center for Evidence Based Medicine-Health Management and Safety Promotion Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran. 50. Department of Health Policy and Administration, University of the Philippines Manila, Manila, The Philippines. 51. Department of Applied Social Sciences, Hong Kong Polytechnic University, Hong Kong, China. 52. Department of Health Promotion and Education, Tehran University of Medical Sciences, Tehran, Iran. 53. School of Health Sciences, Birmingham City University, Birmingham, UK. 54. School of Nursing and Midwifery, Saveh University of Medical Sciences, Saveh, Iran. 55. Social Determinants of Health Research Center, Saveh University of Medical Sciences, Saveh, Iran. 56. School of Science and Health, Western Sydney University, Penrith, New South Wales, Australia. 57. Oral Health Services, Sydney Local Health District, Sydney, New South Wales, Australia. 58. Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. 59. Research Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran. 60. Preventive Medicine and Public Health Research Center, Iran University of Medical Sciences, Tehran, Iran. 61. Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran. 62. Education Development Center, Mashhad University of Medical Sciences, Mashhad, Iran. 63. Non-communicable Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran. 64. Center for Clinical Global Health Education, Johns Hopkins University, Baltimore, MD, USA. 65. Dr D. Y. Patil Medical College, Pune, India. 66. The Judith Lumley Centre, La Trobe University, Melbourne, Victoria, Australia. 67. General Office for Research and Technological Transfer, Peruvian National Institute of Health, Lima, Peru. 68. Department of Family and Community Health, University of Health and Allied Sciences, Ho, Ghana. 69. Center for Infectious Diseases Research, Babol, Iran. 70. Public Health Risk Sciences Division, Public Health Agency of Canada, Toronto, Ontario, Canada. 71. Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada. 72. Department of Chemistry, Sharif University of Technology, Tehran, Iran. 73. Tissue Engineering and Applied Cell Sciences Division, Tarbiat Modares University, Tehran, Iran. 74. Division of Diseases, Advanced Technologies Research Group, Tehran, Iran. 75. School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran. 76. Clinic for Infectious and Tropical Diseases, Clinical Center of Serbia, Belgrade, Serbia. 77. Faculty of Medicine, University of Belgrade, Belgrade, Serbia. 78. Barcelona Institute for Global Health, University of Barcelona, Barcelona, Spain. 79. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. 80. Department of Psychiatry, Melbourne Medical School, Melbourne, Victoria, Australia. 81. Health Human Resources Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. 82. Department of Community Medicine, Gandhi Medical College Bhopal, Bhopal, India. 83. Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan, Italy. 84. Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. 85. Hepatitis Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. 86. Pharmacoepidemiology and Social Pharmacy, Mekelle University, Mekelle, Ethiopia. 87. School of Forestry and Environmental Studies, Yale University, New Haven, CT, USA. 88. Department of Public Health, Arba Minch University, Arba Minch, Ethiopia. 89. Hubert Department of Global Health, Emory University, Atlanta, GA, USA. 90. Department of Global Health, University of South Florida, Tampa, FL, USA. 91. London School of Hygiene & Tropical Medicine, London, UK. 92. Nepal Academy of Science & Technology, Patan, Nepal. 93. The Centre for Global Child Health, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. 94. Center of Excellence in Women and Child Health, Aga Khan University, Karachi, Pakistan. 95. Social Determinants of Health Research Center, Babol University of Medical Sciences, Babol, Iran. 96. Department of Veterinary Medicine, Karaj Islamic Azad University, Kermanshah, Iran. 97. Department of Psychology, Ohio State University, Columbus, OH, USA. 98. Psychiatry and Behavioral Health Department, Ohio State University, Columbus, OH, USA. 99. Neuroscience Department, Institute for Scientific Research and High Technology Services, City of Knowledge, Panama. 100. Gorgas Memorial Institute for Health Studies, Panama, Panama. 101. Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK. 102. Department of Community Medicine, Employees' State Insurance Model Hospital, Bangalore, India. 103. Department for Health Care Management, Technical University of Berlin, Berlin, Germany. 104. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. 105. Al Shifa School of Public Health, Al Shifa Trust Eye Hospital, Rawalpindi, Pakistan. 106. Centre for Population Health Sciences, Nanyang Technological University, Singapore, Singapore. 107. Global Ehealth Unit, Imperial College London, London, UK. 108. Department of Population and Health, Metropolitan Autonomous University, Mexico City, Mexico. 109. Colombian National Health Observatory, National Institute of Health, Bogota, Colombia. 110. Epidemiology and Public Health Evaluation Group, National University of Colombia, Bogota, Colombia. 111. Mary Mackillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia. 112. School of Public Health, University of Hong Kong, Hong Kong, China. 113. Department of Obstetrics and Gynaecology, University of Gondar, Gondar, Ethiopia. 114. Division of Epidemiology, National Institute of Cholera and Enteric Diseases, Kolkata, India. 115. Faculty of Biology, Hanoi National University of Education, Hanoi, Vietnam. 116. Department of Rheumatology, University of Oxford, Oxford, UK. 117. Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK. 118. Applied Molecular Biosciences Unit (UCIBIO), University of Porto, Porto, Portugal. 119. Institute of Public Health Kalyani, Kalyani, India. 120. School of Health Science, Orebro University, Orebro, Sweden. 121. Public Health Foundation of India, Gurugram, India. 122. Toxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran. 123. Department of General Surgery, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. 124. Department of Surgery, Clinical Emergency Hospital St Pantelimon, Bucharest, Romania. 125. Heidelberg Institute of Global Health (HIGH), Heidelberg University, Heidelberg, Germany. 126. Bahir Dar University, Bahir Dar, Ethiopia. 127. School of Pharmacy, Aksum University, Aksum, Ethiopia. 128. Addis Ababa University, Addis Ababa, Ethiopia. 129. School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia. 130. Department of Global Health and Infection, Brighton and Sussex Medical School, Brighton, UK. 131. Division of Cardiology, Atlanta Veterans Affairs Medical Center, Decatur, GA, USA. 132. Public Health Nutrition, Bahir Dar University, Bahir Dar, Ethiopia. 133. Centre for Atmospheric Sciences, Indian Institute of Technology Delhi, New Delhi, India. 134. Department of Community Medicine, University of Peradeniya, Peradeniya, Sri Lanka. 135. Health Research Section, Nepal Health Research Council, Kathmandu, Nepal. 136. Center of Complexity Sciences, National Autonomous University of Mexico, Mexico City, Mexico. 137. Facultad de Medicina Veterinaria y Zootecnia, Autonomous University of Sinaloa, Culiacan Rosales, Mexico. 138. Department of Health Policy and Economy, Tabriz University of Medical Sciences, Tabriz, Iran. 139. School of Medicine, Federal University of Bahia, Salvador, Brazil. 140. Diretoria Médica, Roberto Santos General Hospital, Salvador, Brazil. 141. Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA. 142. Environmental Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran. 143. Clinical Epidemiology and Biostatistics, University of Newcastle, Newcastle, New South Wales, Australia. 144. Department of Toxicology and Pharmacology, Tabriz University of Medical Sciences, Tabriz, Iran. 145. Department of Basic Sciences, Maragheh University of Medical Sciences, Maragheh, Iran. 146. National Institute for Health Researchers, Tehran University of Medical Sciences, Tehran, Iran. 147. Medical Research Institute, Alexandria University, Alexandria, Egypt. 148. Department of Clinical Pathology, Mansoura University, Mansoura, Egypt. 149. Pediatric Dentistry and Dental Public Health, Alexandria University, Alexandria, Egypt. 150. Preventive Dental Sciences, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia. 151. Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden. 152. Ophthalmic Epidemiology Research Center, Shahroud University of Medical Sciences, Shahroud, Iran. 153. Department of Microbiology and Immunology, Suez Canal University, Ismailia, Egypt. 154. Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada. 155. Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada. 156. Babol University of Medical Sciences, Babol, Iran. 157. College of Medicine, Imam Muhammad Ibn Saud Islamic University, Riyadh, Saudi Arabia. 158. Department of Parasitology, Mazandaran University of Medical Sciences, Sari, Iran. 159. Department of Psychology, Federal University of Sergipe, Sao Cristovao, Brazil. 160. Social Determinants of Health Research Center, Hamadan University of Medical Sciences, Hamadan, Iran. 161. Environmental Health Engineering, Tehran University of Medical Sciences, Tehran, Iran. 162. Department of Environmental Health Engineering, Ardabil University of Medical Science, Ardabil, Iran. 163. Department of Public Health Nutrition, Bahir Dar University, Bahir Dar, Ethiopia. 164. Department of Neurobiology, Karolinska Institutet, Stockholm, Sweden. 165. Division of Neurology, University of Ottawa, Ottawa, Ontario, Canada. 166. Center for Biotechnology and Fine Chemistry, Catholic University of Portugal, Porto, Portugal. 167. Psychiatry Department, Kaiser Permanente, Fontana, CA, USA. 168. Department of Health Sciences, A.T. Still University, Mesa, AZ, USA. 169. Department of Public Health Medicine, Bielefeld University, Bielefeld, Germany. 170. Institute of Gerontology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine. 171. Abadan School of Medical Sciences, Abadan, Iran. 172. Clinical Medicine and Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa. 173. Gene Expression & Regulation Program, Cancer Institute (W.I.A.), Philadelphia, PA, USA. 174. Department of Dermatology, Kobe University, Kobe, Japan. 175. Department of Environmental Health Science, Mario Negri Institute for Pharmacological Research, Milan, Italy. 176. Mekelle University, Mekelle, Ethiopia. 177. Dr Tewelde Legesse Health Sciences College, Mekelle, Ethiopia. 178. Department of Epidemiology, Jimma University, Jimma, Ethiopia. 179. School of Nursing, Mekelle University, Mekelle, Ethiopia. 180. Nursing Department, Aksum University, Aksum, Ethiopia. 181. Vaccines Department, Pfizer, Collegeville, PA, USA. 182. Agency of Preventive Medicine, Paris, France. 183. Department of Pharmacy, Wollo University, Dessie, Ethiopia. 184. Health Research Institute, Babol University of Medical Sciences, Babol, Iran. 185. Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran. 186. Department of Health Services Management, Iran University of Medical Sciences, Tehran, Iran. 187. Unit of Academic Primary Care, University of Warwick, Coventry, UK. 188. Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia. 189. School of BioSciences, University of Melbourne, Parkville, Victoria, Australia. 190. Department of Chemistry, University of Porto, Porto, Portugal. 191. REQUIMTE/LAQV, Porto, Portugal. 192. Nursing and Health Sciences Department, University of Massachusetts Boston, Boston, MA, USA. 193. Department of Biostatistics and Epidemiology, University of Oklahoma, Oklahoma City, OK, USA. 194. Department of Health and Social Affairs, Government of the Federated States of Micronesia, Palikir, Federated States of Micronesia. 195. Occupational and Environmental Epidemiology Section, Cancer Prevention and Research Institute, Florence, Italy. 196. Postgraduate Program in Epidemiology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. 197. Department of Primary Care and Public Health, Imperial College London, London, UK. 198. Health Improvement Directorate, Public Health England, London, UK. 199. School of Public Health, University of Haifa, Haifa, Israel. 200. School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. 201. Department of Epidemiology and Biostatistics, Zhengzhou University, Zhengzhou, China. 202. Department of Pharmacology, Tehran University of Medical Sciences, Tehran, Iran. 203. Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 204. Department of Radiology, Johns Hopkins University, Baltimore, MD, USA. 205. Global and Community Mental Health Research Group, University of Macau, Macao, China. 206. School of Health and Environmental Studies, Hamdan Bin Mohammed Smart University, Dubai, United Arab Emirates. 207. Tabriz University of Medical Sciences, Tabriz, Iran. 208. Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain. 209. Research and Development Unit, San Juan de Dios Sanitary Park, Sant Boi De Llobregat, Spain. 210. School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. 211. Healthcare Management, Maragheh University of Medical Sciences, Maragheh, Iran. 212. Department of Microbiology, Tehran University of Medical Sciences, Tehran, Iran. 213. Department of Microbiology, Maragheh University of Medical Sciences, Maragheh, Iran. 214. School of Nursing and Midwifery Tabriz University of Medical Sciences, Tabriz, Iran. 215. Independent Consultant, Tabriz, Iran. 216. Public Health Department, Mizan-Tepi University, Teppi, Ethiopia. 217. Unit of Epidemiology and Social Medicine, University Hospital Antwerp, Antwerp, Belgium. 218. School of Public Health, Curtin University, Bentley, Western Australia, Australia. 219. Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. 220. Population Health, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia. 221. Center of Excellence in Behavioral Medicine, Nguyen Tat Thanh University, Ho Chi Minh, Vietnam. 222. Social Determinants of Health Research Center, Guilan Road Trauma Research Center, Guilan University of Medical Sciences, Rasht, Iran. 223. Guilan Road Trauma Research Center, Guilan University of Medical Sciences, Rasht, Iran. 224. Radiology and Nuclear Medicine Department, Kermanshah University of Medical Sciences, Kermanshah, Iran. 225. Department of Pharmacology and Therapeutics, University of Dhaka, Dhaka, Bangladesh. 226. Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran. 227. Computer Science Department, University of Human Development, Sulaimaniyah, Iraq. 228. Department of Internal Medicine, Bucharest Emergency Hospital, Bucharest, Romania. 229. Faculty of Dentistry, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. 230. Clinical Legal Medicine, National Institute of Legal Medicine Mina Minovici, Bucharest, Romania. 231. Division of Information and Computing Technology, Hamad Bin Khalifa University, Doha, Qatar. 232. Qatar Foundation for Education, Science and Community Development, Doha, Qatar. 233. Faculty of Medicine Tunis, Medicine School of Tunis, Baab Saadoun, Tunisia. 234. Department of Community Medicine, University of Ibadan, Ibadan, Nigeria. 235. Department of Public Health, Lorestan University of Medical Sciences, Khorramabad, Iran. 236. Global Health and Development Department, Taipei Medical University, Taipei City, Taiwan. 237. Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 238. MRC Epidemiology Unit, University of Cambridge, Cambridge, UK. 239. Harvard University, Boston, MA, USA. 240. Institute for Physical Activity and Nutrition, Deakin University, Burwood, Victoria, Australia. 241. Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. 242. Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia. 243. Psychosis Department, Babol Nushirvani University of Technology, Babol, Iran. 244. Psychiatric Department, Kermanshah University of Medical Sciences, Kermanshah, Iran. 245. Department of Medical Mycology, Mazandaran University of Medical Sciences, Sari, Iran. 246. Faculty of Graduate Studies, University of Colombo, Colombo, Sri Lanka. 247. Institute of Medicine, University of Colombo, Colombo, Sri Lanka. 248. School of Midwifery, A.T. Still University, Mesa, AZ, USA. 249. Environmental Research Center, Duke Kunshan University, Kunshan, China. 250. Department of Medicine, University of Miami, Atlantis, FL, USA. 251. Department of Ophthalmology, Heidelberg University, Heidelberg, Germany. 252. Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Beijing, China. 253. Social Determinants of Health Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. 254. Faculty of Medicine and Health Sciences, University of Opole, Opole, Poland. 255. Department of Family Medicine and Public Health, University of Opole, Opole, Poland. 256. Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran. 257. Department of Nutrition and Dietetics, Mekelle University, Mekelle, Ethiopia. 258. Mazandaran University of Medical Sciences, Sari, Iran. 259. Isfahan University of Medical Sciences, Isfahan, Iran. 260. Social Determinants of Health Research Center, Qazvin University of Medical Sciences, Qazvin, Iran. 261. Department of Epidemiology, Hamadan University of Medical Sciences, Hamadan, Iran. 262. Research and Development, Australian Red Cross Blood Service, Sydney, New South Wales, Australia. 263. School of Public Health and Community Medicine, University of New South Wales, Sydney, New South Wales, Australia. 264. Hematologic Malignancies Research Center, Tehran University of Medical Sciences, Tehran, Iran. 265. Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran. 266. Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA, USA. 267. Odel Campus, University of Nairobi, Nairobi, Kenya. 268. Michigan State University, East Lansing, MI, USA. 269. Tabriz Health Management Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. 270. National Institute for Health Research (NIHR), Tehran University of Medical Sciences, Tehran, Iran. 271. Department of Public Health and Community Medicine, Jordan University of Science and Technology, Ramtha, Jordan. 272. Social Determinants of Health Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. 273. Epidemiology and Biostatistics Department, Health Services Academy, Islamabad, Pakistan. 274. Population Studies, International Institute for Population Sciences, Mumbai, India. 275. Department of Internal Medicine, John H. Stroger Jr Hospital of Cook County, Chicago, IL, USA. 276. Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan. 277. Institute of Health Policy and Management, Seoul National University, Seoul, South Korea. 278. Department of Health Policy and Management, Seoul National University, Seoul, South Korea. 279. Faculty of Health and Wellbeing, Sheffield Hallam University, Sheffield, UK. 280. Department of Arts and Sciences, Ohio University, Zanesville, OH, USA. 281. Internal Medicine and Gastroenterology Department, National Hepatology and Tropical Research Institute, Cairo, Egypt. 282. Department of Medical Parasitology, Cairo University, Cairo, Egypt. 283. Department of Environmental Health Engineering, Hamadan University of Medical Sciences, Hamadan, Iran. 284. Department of Public Health, Mazandaran University of Medical Sciences, Sari, Iran. 285. Department of Nutrition and Health Science, Ball State University, Muncie, IN, USA. 286. School of Public Health, Kermanshah University of Medical Sciences, Kermanshah, Iran. 287. School of Medicine, Xiamen University Malaysia, Sepang, Malaysia. 288. Department of Nutrition, Simmons College, Boston, MA, USA. 289. Department of Health Management and Health Economics, Kristiania University College, Oslo, Norway. 290. Department of Health Services Policy and Management, University of South Carolina, Columbia, SC, USA. 291. Nursing and Health Promotion, Oslo Metropolitan University, Oslo, Norway. 292. Department of Public Health, Debre Berhan University, Debre Berhan, Ethiopia. 293. Independent Consultant, Jakarta, Indonesia. 294. Department of Internal and Pulmonary Medicine, Sheri Kashmir Institute of Medical Sciences, Srinagar, India. 295. CIBERSAM, San Juan de Dios Sanitary Park, Sant Boi De Llobregat, Spain. 296. Department of Zoology, University of Oxford, Oxford, UK. 297. Medical School, Harvard University, Boston, MA, USA. 298. Department of Anthropology, Panjab University, Chandigarh, India. 299. Family and Community Health, University of Health and Allied Sciences, Ho, Ghana. 300. Psychology and Health Promotion, University of Kwazulu-Natal, Durban, South Africa. 301. Department of Psychiatry, University of Nairobi, Nairobi, Kenya. 302. Department of Psychology, University College London, London, UK. 303. International Institute for Population Sciences, Mumbai, India. 304. Department of Public Health Medicine, University of Kwazulu-Natal, Durban, South Africa. 305. Nursing, St John of God Hospital, Duayaw Nkwanta, Ghana. 306. Nuffield Department of Population Health, University of Oxford, Oxford, UK. 307. Oxford Biomedical Research Centre, National Institute for Health Research (NIHR), Oxford, UK. 308. Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India. 309. Department of Community and Family Medicine, Academy of Medical Science, Baghdad, Iraq. 310. Department of Medical Sciences, Uppsala University, Uppsala, Sweden. 311. Department of Clinical Chemistry and Pharmacology, Uppsala University Hospital, Uppsala, Sweden. 312. School of Nursing, Hong Kong Polytechnic University, Hong Kong, China. 313. Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia. 314. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, China. 315. Department of Dentistry, Radboud University, Nijmegen, The Netherlands. 316. Section for Translational Health Economics, Heidelberg University Hospital, Heidelberg, Germany. 317. Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK. 318. Alliance for Improving Health Outcomes, Quezon City, The Philippines. 319. Institute of Nutrition, Friedrich Schiller University Jena, Jena, Germany. 320. Competence Cluster for Nutrition and Cardiovascular Health (NUTRICARD), Jena, Germany. 321. Physiology Department, Suez Canal University, Ismailia, Egypt. 322. Proteomics and Metabolomics Unit, Suez Canal University, Ismailia, Egypt. 323. Department of Cardiology, Damietta University, Damietta, Egypt. 324. Ophthalmology Department, Aswan Faculty of Medicine, Aswan, Egypt. 325. Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. 326. Non-communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. 327. Department of Maternal and Child Nursing and Public Health, Federal University of Minas Gerais, Belo Horizonte, Brazil. 328. Institute for Social Science Research, The University of Queensland, Brisbane, Queensland, Australia. 329. Ophthalmology Department, Iran University of Medical Sciences, Tehran, Iran. 330. Department Ophthalmology, University of Manitoba, Winnipeg, Manitoba, Canada. 331. Surgery Department, Emergency University Hospital Bucharest, Bucharest, Romania. 332. Department of Health Education and Health Promotion, Iran University of Medical Sciences, Tehran, Iran. 333. Campus Caucaia, Federal Institute of Education, Science and Technology of Ceará, Caucaia, Brazil. 334. Faculty of Health and Education, Botho University-Botswana, Gaborone, Botswana. 335. Division of Plastic Surgery, University of Washington, Seattle, WA, USA. 336. School of Medicine, University of New South Wales, Sydney, New South Wales, Australia. 337. Research Department, The George Institute for Global Health, New Delhi, India. 338. Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden. 339. Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK. 340. Preventive Oncology Department, National Institute of Cancer Prevention and Research, Noida, India. 341. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA. 342. Peru Country Office, United Nations Population Fund (UNFPA), Lima, Peru. 343. Forensic Medicine Division, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia. 344. Neurocenter, Helsinki University Hospital, Helsinki, Finland. 345. School of Health Sciences, University of Melbourne, Parkville, Victoria, Australia. 346. Breast Surgery Unit, Helsinki University Hospital, Helsinki, Finland. 347. University of Helsinki, Helsinki, Finland. 348. Clinical Microbiology and Parasitology Unit, Dr Zora Profozic Polyclinic, Zagreb, Croatia. 349. University Centre Varazdin, University North, Varazdin, Croatia. 350. Pacific Institute for Research & Evaluation, Calverton, MD, USA. 351. Health, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada. 352. Department of Computer Science and Software Engineering, University of Western Australia, Perth, Western Australia, Australia. 353. Department of Public Health, Amrita Institute of Medical Sciences, Kochi, India. 354. Department of Clinical Biochemistry, Babol University of Medical Sciences, Babol, Iran. 355. Golestan University of Medical Sciences, Gorgan, Iran. 356. Foodborne and Waterborne Diseases Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 357. Faculty of General Medicine, Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan. 358. Department of Atherosclerosis and Coronary Heart Disease, National Center of Cardiology and Internal Disease, Bishkek, Kyrgyzstan. 359. Health Equity Research Center, Tehran University of Medical Sciences, Tehran, Iran. 360. Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. 361. Department of Food Technology, College of Agriculture, Salahaddin University-Erbil, Erbil, Iraq. 362. Information Technology Department, University of Human Development, Sulaimaniyah, Iraq. 363. Department of Biostatistics, Hamadan University of Medical Sciences, Hamadan, Iran. 364. School of Pharmacy, Haramaya University, Harar, Ethiopia. 365. Institute of Public Health, Heidelberg University, Heidelberg, Germany. 366. Health Systems and Policy Research Unit, Ahmadu Bello University, Zaria, Nigeria. 367. Faculty of Life Sciences and Medicine, King's College London, London, UK. 368. Clinical Epidemiology and Public Health Research Unit, Burlo Garofolo Institute for Maternal and Child Health, Trieste, Italy. 369. Health Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran. 370. Department of Epidemiology and Biostatistics, Kurdistan University of Medical Sciences, Sanandaj, Iran. 371. Social Determinants of Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran. 372. Department of Epidemiology, Iran University of Medical Sciences, Tehran, Iran. 373. Department of Mathematical Sciences, University of Bath, Bath, UK. 374. International Laboratory for Air Quality and Health, Queensland University of Technology, Brisbane, Queensland, Australia. 375. Department of Clinical Biochemistry, Tarbiat Modares University, Tehran, Iran. 376. Department of Health Management and Economics, Tehran University of Medical Sciences, Tehran, Iran. 377. Federal Institute for Population Research, Wiesbaden, Germany. 378. Center for Population and Health, Wiesbaden, Germany. 379. Department of Epidemiology and Biostatistics, University of Gondar, Gondar, Ethiopia. 380. Department of Pediatric Medicine, Nishtar Medical University, Multan, Pakistan. 381. Department of Pediatrics & Pediatric Pulmonology, Institute of Mother & Child Care, Multan, Pakistan. 382. Department of Urology, Tehran University of Medical Sciences, Tehran, Iran. 383. Operating Room Department, Kermanshah University of Medical Sciences, Kermanshah, Iran. 384. Research and Analytics, Initiative for Financing Health and Human Development, Chennai, India. 385. Research and Analytics, Bioinsilico Technologies, Chennai, India. 386. Cancer Research Center of Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. 387. Department of Epidemiology & Biostatistics, Kermanshah University of Medical Sciences, Kermanshah, Iran. 388. Suraj Eye Institute, Nagpur, India. 389. Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa. 390. Emergency Hospital of Bucharest, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. 391. General Surgery Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. 392. Anatomy and Embryology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. 393. Department of Cardiology, Cardio-aid, Bucharest, Romania. 394. Department of Biological Sciences, University of Embu, Embu, Kenya. 395. Institute for Global Health Innovations, Duy Tan University, Hanoi, Vietnam. 396. Center for Excellence in Behavioral Health, Nguyen Tat Thanh University, Ho Chi Minh, Vietnam. 397. Global Health Department, University of Washington, Seattle, WA, USA. 398. Department of Pediatrics, University of Washington, Seattle, WA, USA. 399. State University of Semarang, Public Health Science Department, Kota Semarang, Indonesia. 400. Graduate Institute of Biomedical Informatics, Taipei Medical University, Taipei City, Taiwan. 401. Clinical Pharmacy Unit, Mekelle University, Mekelle, Ethiopia. 402. Public Health Science Department, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. 403. Department of Community and Family Medicine, Iran University of Medical Sciences, Tehran, Iran. 404. University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. 405. Department of Health Economics, Tabriz University of Medical Sciences, Tabriz, Iran. 406. Department of Medicine, University of Cape Town, Cape Town, South Africa. 407. Centre of Cardiovascular Research and Education in Therapeutics, Monash University, Melbourne, Victoria, Australia. 408. Independent Consultant, Accra, Ghana. 409. Translational Health Research Institute, Western Sydney University, Penrith, New South Wales, Australia. 410. Center for the Aid Program of Research in South Africa (CAPRISA) TB and HIV Pathogenesis Unit, United Nations Programme on HIV/AIDS (UNAIDS), Durban, South Africa. 411. Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada. 412. Department of Psychiatry, University of Lagos, Lagos, Nigeria. 413. Gastroenterology and Liver Disease Research Center, A.C.S. Medical College and Hospital, Tehran, Iran. 414. Department of Food Science and Postharvest Technology, Gulu University, Gulu, Uganda. 415. Ghent University, Ghent, Belgium. 416. Centre for Healthy Start Initiative, Lagos, Nigeria. 417. Department of Health Promotion and Education, University of Ibadan, Ibadan, Nigeria. 418. Department of Pharmacology and Therapeutics, University of Nigeria Nsukka, Enugu, Nigeria. 419. University of Washington, Seattle, WA, USA. 420. Graduate School of Public Health, San Diego State University, San Diego, CA, USA. 421. Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico. 422. School of Medicine, Autonomous University of Madrid, Madrid, Spain. 423. Department of Nephrology and Hypertension, The Institute for Health Research Foundation Jiménez Díaz University Hospital, Madrid, Spain. 424. Environmental Management and Toxicology, University of Benin, Benin City, Nigeria. 425. Faculty of Geoinformation Science and Earth Observation, University of Twente, Enschede, The Netherlands. 426. Department of Mathematics and Statistics, University of Energy and Natural Resources, Sunyani, Ghana. 427. Analytical Center, Moscow Institute of Physics and Technology, Dolgoprudny, Russia. 428. Committee for the Comprehensive Assessment of Medical Devices and Information Technology, Health Technology Assessment Association, Moscow, Russia. 429. Institute for Advanced Medical Research and Training, University of Ibadan, Ibadan, Nigeria. 430. Department of Tb & Respiratory Medicine, Jagadguru Sri Shivarathreeswara University, Mysore, India. 431. Department of Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. 432. Heidelberg University, Heidelberg, Germany. 433. Department of Medical Humanities and Social Medicine, Kosin University, Busan, South Korea. 434. Research and Evaluation, Population Council, New Delhi, India. 435. Indian Institute of Health Management Research University, Jaipur, India. 436. Center for Research and Innovation, Ateneo De Manila University, Pasig City, The Philippines. 437. Department of Genetics, Harvard University, Boston, MA, USA. 438. Laboratory of Genetics and Molecular Cardiology, University of São Paulo, Sao Paulo, Brazil. 439. Department of Cardiology, University of Bern, Bern, Switzerland. 440. Parasitology and Entomology Department, Tarbiat Modares University, Tehran, Iran. 441. National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark. 442. Department of Nutrition and Food Sciences, Maragheh University of Medical Sciences, Maragheh, Iran. 443. Department of Public Health, Maragheh University of Medical Sciences, Maragheh, Iran. 444. Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran. 445. Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran. 446. College of Graduate Health Sciences, A.T. Still University, Mesa, AZ, USA. 447. Medichem, Barcelona, Spain. 448. Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran. 449. Department of Immunology, Mazandaran University of Medical Sciences, Sari, Iran. 450. Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. 451. Thalassemia and Hemoglobinopathy Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. 452. Department of Clinical Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran. 453. Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran. 454. Department of Health Education & Promotion, Kermanshah University of Medical Sciences, Kermanshah, Iran. 455. Department of Nephrology, Nizam's Institute of Medical Sciences, Hyderabad, India. 456. Prevention of Metabolic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 457. Critical Care Quality Improvement Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 458. Policy Research Institute, Kathmandu, Nepal. 459. Institute for Poverty Alleviation and International Development, Yonsei University, Wonju, South Korea. 460. Institute of Public Health, Federal University of Bahia, Salvador, Brazil. 461. Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil. 462. School of Behavioral Sciences and Mental Health, Iran University of Medical Sciences, Tehran, Iran. 463. Social Science and Psychology, Western Sydney University, Penrith, New South Wales, Australia. 464. School of Social Sciences and Psychology, Western Sydney University, Penrith, New South Wales, Australia. 465. Research Center for Environmental Determinants of Health (RCEDH), Kermanshah University of Medical Sciences, Kermanshah, Iran. 466. Department of Epidemiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 467. Department of Epidemiology, Birjand University of Medical Sciences, Birjand, Iran. 468. EPIUnit, University of Porto, Porto, Portugal. 469. Department of Clinical Research, Federal University of Uberlândia, Uberlândia, Brazil. 470. Public Health, Addis Ababa University, Addis Ababa, Ethiopia. 471. Department of Public Health, Wollega University, Nekemte, Ethiopia. 472. Martin School, University of Oxford, Oxford, UK. 473. Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran. 474. Epidemiology and Biostatistics, Kurdistan University of Medical Sciences, Sanandaj, Iran. 475. Infectious Diseases and Tropical Medicine Research Center, Babol University of Medical Sciences, Babol, Iran. 476. School of Biotechnology, Ikiam Amazon Regional University, Tena, Ecuador. 477. Department of Ocean Science and Engineering, Southern University of Science and Technology, Shenzhen, China. 478. Department of Biomedical Sciences, University of Sassari, Sassari, Italy. 479. Department of Health, Safety and Environment (HSE), Shahid Beheshti University of Medical Sciences, Tehran, Iran. 480. Faculty of Public Health, Kermanshah University of Medical Sciences, Kermanshah, Iran. 481. Department of Neuroscience, Iran University of Medical Sciences, Tehran, Iran. 482. Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. 483. Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. 484. Department of Anatomical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran. 485. Department of Pathology, Al-Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia. 486. School of Health and Policy Management, Faculty of Health, York University, Toronto, Ontario, Canada. 487. Taleghani Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran. 488. Department of Radiology and Nuclear Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. 489. Taleghani Hospital, Kermanshah, Iran. 490. Center for Health Policy & Center for Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA. 491. Department of Entomology, Ain Shams University, Cairo, Egypt. 492. Centre School of Public Health and Health Management, University of Belgrade, Belgrade, Serbia. 493. Post-graduate Program in Infectious Diseases and Tropical Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil. 494. Department of Community Medicine, PSG Institute of Medical Sciences and Research, Coimbatore, India. 495. PSG-FAIMER South Asia Regional Institute, Coimbatore, India. 496. Department of Health and Society, Faculty of Medicine, University of Applied and Environmental Sciences, Bogotá, Colombia. 497. Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK. 498. Surgery Department, Hamad Medical Corporation, Doha, Qatar. 499. Faculty of Health & Social Sciences, Bournemouth University, Bournemouth, UK. 500. School of Public Health, Imperial College London, London, UK. 501. Department of Psychology, University of Alabama at Birmingham, Birmingham, AL, USA. 502. Center of Expertise in Microbiology, Tehran University of Medical Sciences, Tehran, Iran. 503. Invasive Fungi Research Center, Mazandaran University of Medical Sciences, Sari, Iran. 504. Department of Health Promotion and Education, Alborz University of Medical Sciences, Karaj, Iran. 505. Independent Consultant, Karachi, Pakistan. 506. School of Medicine, Dezful University of Medical Sciences, Dezful, Iran. 507. Medical Laboratory Sciences, Mazandaran University of Medical Sciences, Sari, Iran. 508. Chronic Diseases (Home Care) Research Center, Hamadan University of Medical Sciences, Hamadan, Iran. 509. Department of Laboratory Sciences, Karaj Islamic Azad University, Kermanshah, Iran. 510. Department of Basic Sciences, Karaj Islamic Azad University, Kermanshah, Iran. 511. HIV/STI Surveillance Research Center, Kerman University of Medical Sciences, Kerman, Iran. 512. Policy and Planning Division, Ministry of Health, Riyadh, Saudi Arabia. 513. University School of Management and Entrepreneurship, Delhi Technological University, New Delhi, India. 514. Division of General Internal Medicine and Primary Care, Harvard University, Boston, MA, USA. 515. Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK. 516. National Institute of Infectious Diseases, Tokyo, Japan. 517. Finnish Institute of Occupational Health, Helsinki, Finland. 518. Institute of Medical Epidemiology, Martin Luther University Halle-Wittenberg, Halle, Germany. 519. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA. 520. Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. 521. Department of Epidemiology, School of Preventive Oncology, Patna, India. 522. Department of Epidemiology, Healis Sekhsaria Institute for Public Health, Mumbai, India. 523. Department of Physiotherapy and Occupational Therapy, Næstved-Slagelse-Ringsted Hospitals, Slagelse, Denmark. 524. Medical Division, German Leprosy and TB Relief Association Ethiopia, Addis Ababa, Ethiopia. 525. Department of Medicine, University of Washington, Seattle, WA, USA. 526. Department of Medicine, University of Calgary, Calgary, Alberta, Canada. 527. Social Development and Health Promotion Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. 528. Hospital Universitario de la Princesa, Autonomous University of Madrid, Madrid, Spain. 529. Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Institute of Health Carlos III, Madrid, Spain. 530. Division of Community Medicine, International Medical University, Kuala Lumpur, Malaysia. 531. Department of Nursing, Muhammadiyah University of Surakarta, Kartasura, Indonesia. 532. Department of Community Medicine, Ahmadu Bello University, Zaria, Nigeria. 533. Department of Criminology, Law and Society, University of California Irvine, Irvine, CA, USA. 534. Neurology Department, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India. 535. Carlos III Health Institute, Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Madrid, Spain. 536. Department of Medicine, University of Valencia, Valencia, Spain. 537. School of Social Work, University of Illinois, Urbana, IL, USA. 538. Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan. 539. University Institute 'Egas Moniz', Monte Da Caparica, Portugal. 540. Research Institute for Medicines, Faculty of Pharmacy of Lisbon, University of Lisbon, Lisbon, Portugal. 541. Department of Pediatrics, King Saud University, Riyadh, Saudi Arabia. 542. College of Medicine, Alfaisal University, Riyadh, Saudi Arabia. 543. Anesthesiology Department, University of Virginia, Charlottesville, VA, USA. 544. Syrian Expatriate Medical Association (SEMA), Charlottesville, VA, USA. 545. Department of Public Health and Community Medicine, Central University Kerala, Kasaragod, India. 546. Nanyang Technological University, Singapore, Singapore. 547. School of Exercise and Nutrition Sciences, Queensland University of Technology, Brisbane, Queensland, Australia. 548. Department of Pathology and Legal Medicine, University of São Paulo, Sao Paulo, Brazil. 549. Department of Health Economics, Hanoi Medical University, Hanoi, Vietnam. 550. Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand. 551. Clinical Hematology and Toxicology, Military Medical University, Hanoi, Vietnam. 552. Gomal Center of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan, Pakistan. 553. TB Culture Laboratory, Mufti Mehmood Memorial Teaching Hospital, Dera Ismail Khan, Pakistan. 554. Division of Health Sciences, University of Warwick, Coventry, UK. 555. Department of Education and Health, Trauma Research Center, Tehran, Iran. 556. Critical and Intensive Care Department, Trauma Research Center, Tehran, Iran. 557. Argentine Society of Medicine, Buenos Aires, Argentina. 558. Velez Sarsfield Hospital, Buenos Aires, Argentina. 559. University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. 560. Department of General Practice, University Medical Center Groningen, Groningen, The Netherlands. 561. Ukk Institute, Tampere, Finland. 562. Psychosocial Injuries Research Center, Ilam University of Medical Sciences, Ilam, Iran. 563. Raffles Neuroscience Centre, Raffles Hospital, Singapore, Singapore. 564. Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. 565. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. 566. Occupational Health Unit, Sant'orsola Malpighi Hospital, Bologna, Italy. 567. Department of Information Technologies and Management, Moscow Institute of Physics and Technology, Dolgoprudny, Russia. 568. Department of Information and Internet Technologies, I. M. Sechenov First Moscow State Medical University, Moscow, Russia. 569. Department of Health Care Administration and Economy, National Research University Higher School of Economics, Moscow, Russia. 570. Foundation University Medical College, Foundation University, Rawalpindi, Pakistan. 571. Department of Statistics, University of Washington, Seattle, WA, USA. 572. Department of Epidemiology and Biostatistics, Wuhan University, Wuhan, China. 573. Department of Psychiatry, University of São Paulo, Sao Paulo, Brazil. 574. Institute of Child Health, University College London, London, UK. 575. Cardiology Department, Royal Children's Hospital, Melbourne, Victoria, Australia. 576. Murdoch Childrens Research Institute, Melbourne, Victoria, Australia. 577. School of Nursing, Aksum University, Aksum, Ethiopia. 578. Competence Center of Mortality-Follow-Up, Federal Institute for Population Research, Wiesbaden, Germany. 579. Cochrane South Africa, Medical Research Council South Africa, Cape Town, South Africa. 580. Department of Global Health, Stellenbosch University, Cape Town, South Africa. 581. Department of Pharmacology and Toxicology, Mekelle University, Mekelle, Ethiopia. 582. Department of Pharmacology, Addis Ababa University, Addis Ababa, Ethiopia. 583. Zhejiang Spine Research Center, Wenzhou Medical University, Wenzhou, China. 584. School of Medicine, Nanjing University, Nanjing, China. 585. Department of Diabetes and Metabolic Diseases, University of Tokyo, Tokyo, Japan. 586. Department of Health Management, Policy and Economics, Kerman University of Medical Sciences, Kerman, Iran. 587. Health Services Management Research Center, Kerman University of Medical Sciences, Kerman, Iran. 588. Department of Pediatrics, University of Jos, Jos, Nigeria. 589. Department of Pediatrics, Jos University Teaching Hospital, Jos, Nigeria. 590. Centre for Suicide Research and Prevention, University of Hong Kong, Hong Kong, China. 591. Department of Social Work and Social Administration, University of Hong Kong, Hong Kong, China. 592. Department of Psychopharmacology, National Center of Neurology and Psychiatry, Tokyo, Japan. 593. Health Economics & Finance, Global Health, Jackson State University, Jackson, MS, USA. 594. Research Center for Public Health, Tsinghua University, Peking, China. 595. Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 596. Medical Parasitology Department, Cairo University, Cairo, Egypt. 597. Global Health Institute, Wuhan University, Wuhan, China. 598. Department of Health Management and Economics, A.C.S. Medical College and Hospital, Tehran, Iran. 599. Department of Electrical Engineering, Sharif University of Technology, Tehran, Iran. 600. Electrical Engineering, Institute for Research in Fundamental Sciences, Tehran, Iran. 601. Social Determinants of Health Research Center, Ardabil University of Medical Science, Ardabil, Iran. 602. Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research Bangladesh, Dhaka, Bangladesh. 603. Department of Medicine, Monash University, Melbourne, Victoria, Australia. 604. Student Research Committee, Babol University of Medical Sciences, Babol, Iran. 605. Department of Community Medicine, Ardabil University of Medical Science, Ardabil, Iran. 606. Maternal and Child Wellbeing Unit, African Population Health Research Centre, Nairobi, Kenya. 607. Public Health Department, Dilla University, Dilla, Ethiopia. 608. Department of Preventative Medicine, Wuhan University, Wuhan, China. 609. School of Public Health, Wuhan University of Science and Technology, Wuhan, China. 610. Indian Institute of Public Health, Public Health Foundation of India, Gurugram, India. 611. Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA. sihay@uw.edu. 612. Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA. sihay@uw.edu.
Abstract
Since 2000, many countries have achieved considerable success in improving child survival, but localized progress remains unclear. To inform efforts towards United Nations Sustainable Development Goal 3.2-to end preventable child deaths by 2030-we need consistently estimated data at the subnational level regarding child mortality rates and trends. Here we quantified, for the period 2000-2017, the subnational variation in mortality rates and number of deaths of neonates, infants and children under 5 years of age within 99 low- and middle-income countries using a geostatistical survival model. We estimated that 32% of children under 5 in these countries lived in districts that had attained rates of 25 or fewer child deaths per 1,000 live births by 2017, and that 58% of child deaths between 2000 and 2017 in these countries could have been averted in the absence of geographical inequality. This study enables the identification of high-mortality clusters, patterns of progress and geographical inequalities to inform appropriate investments and implementations that will help to improve the health of all populations.
Since 2000, many countries have achieved considerable success in improving child survival, but localized progress remains unclear. To inform efforts towards United Nations Sustainable Development Goal 3.2-to end preventable child deaths by 2030-we need consistently estimated data at the subnational level regarding child mortality rates and trends. Here we quantified, for the period 2000-2017, the subnational variation in mortality rates and number of deaths of neonates, infants and children under 5 years of age within 99 low- and middle-income countries using a geostatistical survival model. We estimated that 32% of children under 5 in these countries lived in districts that had attained rates of 25 or fewer child deaths per 1,000 live births by 2017, and that 58% of child deaths between 2000 and 2017 in these countries could have been averted in the absence of geographical inequality. This study enables the identification of high-mortality clusters, patterns of progress and geographical inequalities to inform appropriate investments and implementations that will help to improve the health of all populations.
Gains in child survival have long served as an important proxy measure for improvements in overall population health and development[1,2]. Global progress in reducing child deaths has been heralded as one of the greatest success stories of global health[3]. The annual global number of deaths of children under 5 years of age (under 5)[4] has declined from 19.6 million in 1950 to 5.4 million in 2017. Nevertheless, these advances in child survival have been far from universally achieved, particularly in low- and middle-income countries (LMICs)[4]. Previous subnational child mortality assessments at the first (that is, states or provinces) or second (that is, districts or counties) administrative level indicate that extensive geographical inequalities persist[5-7].Progress in child survival also diverges across age groups[4]. Global reductions in mortality rates of children under 5—that is, the under-5 mortality rate (U5MR)—among post-neonatal age groups are greater than those for mortality of neonates (0–28 days)[4,8]. It is relatively unclear how these age patterns are shifting at a more local scale, posing challenges to ensuring child survival. To pursue the ambitious Sustainable Development Goal (SDG) of the United Nations[9] to “end preventable deaths of newborns and children under 5” by 2030, it is vital for decision-makers at all levels to better understand where, and at what ages, child survival remains most tenuous.
Precision public health and child mortality
Country-level estimates facilitate international comparisons but mask important geographical heterogeneity. Previous assessments of mortality of children under 5 have noted significant within-country heterogeneity, particularly in sub-Saharan Africa[5,7,10-14], as well as in Brazil[15], Iran[16] and China[17]. Understanding public health risks at more granular subpopulation levels is central to the emerging concept of precision public health[18], which uses “the best available data to target more effectively and efficiently interventions…to those most in need”[18]. Efforts to produce high-resolution estimates of mortality of children under 5, determinants at scales that cover the multiple countries are emerging, including for vaccine coverage[19,20], malaria[21], diarrhoea[22] and child growth failure[23,24]. In a previous study, we produced comprehensive estimates of African child mortality rates at a 5 × 5-km scale for 5-year intervals[5]. For areas outside of Africa, in which 72% of the world’s children live and 46% of global child deaths occurred in 2017[4], subnational heterogeneity remains mostly undescribed[25].Here we produce estimates of death counts and mortality rates of children under 5, infants (under 1 years of age) and neonates (0–28 days) in 99 countries at policy-relevant subnational scales (first and second administrative levels) for each year from 2000 to 2017. We fit a geostatistical discrete hazards model to a large dataset that is composed of 467 geo-referenced household surveys and censuses, representing approximately 15.9 million births and 1.1 million deaths of children from 2000 to 2017. Our model includes socioeconomic, environmental and health-related spatial covariates with known associations to child mortality and uses a Gaussian process random effect to exploit the correlation between data points near each other across dimensions of space, time and age group, which helps to mitigate the limitations associated with data sparsity in our estimations. For this study, we report U5MR as the expected number of deaths per 1,000 live births, reflecting the probability of dying before the age of 5 for a given location and year.
Unequal rates of child mortality
The risk of a newborn dying before their fifth birthday varies tremendously based on where in the world, and within their country, they are born. Across the 99 countries in this study, we estimate that U5MR varied as much as 24-fold at the national level in 2017, with the highest rate in the Central African Republic of 123.9 deaths (95% uncertainty interval, 104.9–148.2) per 1,000 live births, and the lowest rate in Cuba of 5.1 deaths (4.4–6.0)[4]. We observed large subnational variation within countries in which overall U5MR was either high or comparatively low. For example, in Vietnam, rates across second administrative units (henceforth referred to as ‘units’) varied 5.7-fold, from 6.9 (4.6–9.8) in the Tenth District in Hồ Chí Minh City to 39.7 (28.1–55.6) in Mường Tè District in the Northwest region (Figs. 1b, 2).
Fig. 1
U5MR estimates in 99 LMICs.
a, U5MR at the second administrative level in 2000. b, U5MR at the second administrative level in 2017. c, Modelled posterior exceedance probability that a given second administrative unit had achieved the SDG 3.2 target of 25 deaths per 1,000 live births for children under 5 in 2017. d, Proportion of mortality of children under 5 occurring in the neonatal (0–28 days) group at the second administrative level in 2017.
Fig. 2
Geographical inequality in U5MR across 99 countries for 2000 and 2017.
a, Absolute inequalities. Range of U5MR estimates in second administrative-level units across 99 LMICs. b, Relative inequalities. Range of ratios of U5MR estimates in second administrative-level units relative to country means. Each dot represents a second administrative-level unit. The lower bound of each bar represents the second administrative-level unit with the lowest U5MR in each country. The upper end of each bar represents the second administrative-level unit with the highest U5MR in each country. Thus, each bar represents the extent of geographical inequality in U5MRs estimated for each country. Bars indicating the range in 2017 are coloured according to their Global Burden of Disease super-region. Grey bars indicate the range in U5MR in 2000. The diamond in each bar represents the median U5MR estimated across second administrative-level units in each country and year. A coloured bar that is shorter than its grey counterpart indicates that geographical inequality has narrowed.
U5MR estimates in 99 LMICs.
a, U5MR at the second administrative level in 2000. b, U5MR at the second administrative level in 2017. c, Modelled posterior exceedance probability that a given second administrative unit had achieved the SDG 3.2 target of 25 deaths per 1,000 live births for children under 5 in 2017. d, Proportion of mortality of children under 5 occurring in the neonatal (0–28 days) group at the second administrative level in 2017.
Geographical inequality in U5MR across 99 countries for 2000 and 2017.
a, Absolute inequalities. Range of U5MR estimates in second administrative-level units across 99 LMICs. b, Relative inequalities. Range of ratios of U5MR estimates in second administrative-level units relative to country means. Each dot represents a second administrative-level unit. The lower bound of each bar represents the second administrative-level unit with the lowest U5MR in each country. The upper end of each bar represents the second administrative-level unit with the highest U5MR in each country. Thus, each bar represents the extent of geographical inequality in U5MRs estimated for each country. Bars indicating the range in 2017 are coloured according to their Global Burden of Disease super-region. Grey bars indicate the range in U5MR in 2000. The diamond in each bar represents the median U5MR estimated across second administrative-level units in each country and year. A coloured bar that is shorter than its grey counterpart indicates that geographical inequality has narrowed.Decreases in U5MR between 2000 and 2017 were evident to some extent throughout all units (Figs. 1a, b, 2). No unit showed a significant increase in U5MR in this period, and in most units U5MR decreased greatly, even in units in which the mortality risk was the highest. Out of 17,554 units, 60.3% (10,585 units) showed a significant (defined as 95% uncertainty intervals that did not overlap) decrease in U5MR between 2000 and 2017. Across units in 2000, U5MR ranged from 7.5 (5.0–10.6) in Santa Clara district, Villa Clara province, Cuba, to 308.4 (274.9–348.4) in the Sabon Birni Local Government Area of Sokoto State, Nigeria. By 2017, the unit with the highest estimated U5MR across all 99 countries was Garki Local Government Area, Jigawa state, Nigeria, at 195.1 (158.6–230.9). Overall, the total percentage of units with a U5MR higher than 80 deaths per 1,000 live births decreased from 28.9% (5,070) of units in 2000 to 7.0% (1,236) in 2017. Furthermore, 32% of units, representing 11.9% of the under-5 population in the 99 countries, had already met SDG 3.2 for U5MR with a 90% certainty threshold (Fig. 1c). For neonatal mortality, 34% of units met the target of ≤12 deaths per 1,000 live births (Extended Data Fig. 1). Within countries, successes were mixed in some cases. For example, Colombia, Guatemala, Libya, Panama, Peru and Vietnam had all achieved SDG 3.2 for U5MR at the national level by 2017, but each country had units that did not achieve the goal with 90% certainty (Fig. 1c).
Extended Data Fig. 1
Neonatal and infant mortality rates in 2017.
a, b, Maps showing the mortality rates of neonates (a; birth to 28 days of age) and infants (b; under 1 year of age) across second administrative-level units in 2017. Note that the ranges in the keys are different for the two maps.
Successful reductions in child mortality were also observed throughout entire countries. For example, in 43 LMICs across several world regions, the worst-performing unit in 2017 had a U5MR that was lower than the best-performing unit in 2000 (Fig. 2). Nearly half of these countries were in sub-Saharan Africa. Rwanda showed notable progress during the study period, reducing mortality from 144.0 (130.0–161.6) in its best-achieving district in 2000 (Rubavu) to 57.2 (47.4–72.1) in its worst-achieving district in 2017 (Kayonza). These broad reductions in U5MR have also led to a convergence of absolute subnational geographical inequalities, although relative subnational inequalities appear to be mostly unchanged between 2000 and 2017 (Fig. 2 and Supplementary Fig. 6.12). Despite this success, the highest U5MRs in 2017 were still largely concentrated in areas in which rates were highest in 2000 (Fig. 1a, b). We observed estimated U5MR ≥ 80 across large geographical areas in Western and Central sub-Saharan Africa, and within Afghanistan, Cambodia, Haiti, Laos and Myanmar (Fig. 1b).Deaths of neonates (0–28 days of age) and post-neonates (28–364 days of age) have come to encompass a larger fraction of overall mortality of children under 5 in recent years. By 2017 (Fig. 1d), neonatal mortality increased as a proportion of total deaths of children under 5 in 91% (90) of countries and for 83% (14,656) of units compared to 2000. In almost all places where U5MR decreased, the share of the mortality burden increased in the groups of children with younger ages. Similarly, the mortality of infants (<1 year) has increased relative to the mortality for children who are 1–4 years of age in many areas. For example, in the Diourbel Region, Senegal, infant mortality constituted 54.4% (52.4–56.6) of total mortality of children under 5 in 2000; by 2017, the relative contribution of infant mortality was 73.2% (70.3–75.8). This shift towards mortality predominantly affecting neonates and infants was not as evident in all locations; mortality for children aged 1–4 years was responsible for more than 30% of overall under-5 deaths in 13% (2,226) of units, mostly within high-mortality areas in sub-Saharan Africa.
Distribution of under-5 deaths may not follow rates
The goal of mortality-reduction efforts is ultimately to prevent premature deaths, and not just to reduce mortality rates. Across the countries studied here, there were 3.5 million (41%) fewer deaths of children under 5 in 2017 than in 2000 (5.0 million compared to 8.5 million). At the national level, the largest number of child deaths in 2017 occurred in India (1.04 (0.98–1.10) million), Nigeria (0.79 (0.65–0.96) million), Pakistan (0.34 (0.27–0.41) million) and the Democratic Republic of the Congo (0.25 (0.21–0.31) million) (Fig. 3a). Within these countries, the geographical concentration of the deaths of the children varied. In Pakistan, over 50% of child deaths in 2017 occurred in Punjab province, which had a U5MR of 63.3 (54.1–76.0) deaths per 1,000 live births (Fig. 3b). By contrast, 50% of child deaths in the Democratic Republic of the Congo in 2017 occurred across 9 out of 26 provinces. Such findings are in a large part artefacts of how borders are drawn around various at-risk populations (the provinces above account for 53% and 63%, respectively, of the under-5 population that is at risk in these two countries), but can have a real impact at the level at which planning occurs. Some concentrated areas with apparent high absolute numbers of deaths highlighted by local-level estimates become less noticeable when reporting at aggregated administrative levels; for example, areas across Guatemala, Honduras and El Salvador are visually striking hotspots in Fig. 3d, but less so in Fig. 3b, c.
Fig. 3
Estimated number of children under 5 who died within 99 countries in 2017.
a, Number of deaths of children under 5 in each country. b, Number of deaths in each first administrative-level unit. c, Number of deaths in each second administrative-level unit. d, Number of deaths of children under 5 in each 5 × 5-km grid cell. Note that scales vary for each aggregation unit.
Estimated number of children under 5 who died within 99 countries in 2017.
a, Number of deaths of children under 5 in each country. b, Number of deaths in each first administrative-level unit. c, Number of deaths in each second administrative-level unit. d, Number of deaths of children under 5 in each 5 × 5-km grid cell. Note that scales vary for each aggregation unit.Our estimates indicate that targeting areas with a ‘high’ U5MR of 80 will have a lower overall effect than in previous years owing to the reductions in mortality rates. In 2000, 23.7% of child deaths—representing 2.0 (1.7–2.4) million deaths—occurred in regions in which U5MR was less than 80 that year (Fig. 4). By comparison, in 2017, 69.5% of child deaths occurred in areas in which U5MR was below 80. A growing proportion of deaths of children under 5 are occurring in ‘low’-mortality areas; 7.3% (5.1–10.2) of all deaths of children under 5 in 2017 occurred in locations in which the U5MR was below the SDG 3.2 target rate of 25, compared to 1.2% (0.9–1.6) in 2000. For instance, Lima, Peru, has a U5MR in the 8th percentile of units in this study, yet it ranks in the 96th percentile of highest number of deaths of children under 5.
Fig. 4
Number of deaths of children under 5, distributed across level of U5MR, in 2000 and in 2017, across 99 countries.
Bar heights represent the total number of deaths of children under 5 within all second administrative-level units with corresponding U5MR. Bins are a width of 5 deaths per 1,000 live births. The colour of each bar represents the global region as defined by the subset legend map. As such, the sum of heights of all bars represents the total number of deaths across the 99 countries. a, Deaths of children under 5 in 2000. b, Deaths of children under 5 in 2017. The dotted line in the 2000 plot is the shape of the distribution in 2017, and the dotted line in the 2017 plot represents the distribution in 2000.
Number of deaths of children under 5, distributed across level of U5MR, in 2000 and in 2017, across 99 countries.
Bar heights represent the total number of deaths of children under 5 within all second administrative-level units with corresponding U5MR. Bins are a width of 5 deaths per 1,000 live births. The colour of each bar represents the global region as defined by the subset legend map. As such, the sum of heights of all bars represents the total number of deaths across the 99 countries. a, Deaths of children under 5 in 2000. b, Deaths of children under 5 in 2017. The dotted line in the 2000 plot is the shape of the distribution in 2017, and the dotted line in the 2017 plot represents the distribution in 2000.Despite population growth, child deaths have declined due to the outpaced decline in U5MR. For example, there were a total of 8.5 (7.2–10.0) million deaths of children under 5 in the countries in this study in 2000; had the 2017 under-5 population been exposed to the same U5MRs that were observed in 2000, there would have been 10.6 (9.0–12.5) million deaths in 2017. Instead, we observed 5.0 (3.8–6.6) million deaths in 2017 (Extended Data Fig. 5).
Extended Data Fig. 5
The counteracting forces of population change and mortality rate decline on total number of under-5 deaths.
Arrow plots show the mortality rate strata (bins of 10 per 1,000 livebirths) in 2000.
Finally, we combine estimates of subnational variation in mortality rates and populations to gain a better understanding of the impact of geographical inequality. Overall, 2.7 (2.5–2.9) million deaths, or 54% of the total number of deaths of children under 5, would have been averted in 2017 had all units had a U5MR that matched the best-performing unit in each respective country (Extended Data Fig. 2). Over the 2000–2017 period, this number is 71.8 (68.5–74.9) million deaths, or 58% (55–61) of the total number of deaths of children under 5. Total deaths attributable to inequality in this scenario ranged from 13 (6–24) deaths in Belize to 0.84 (0.72–0.99) million deaths in India. Furthermore, had all units met the SDG 3.2 target of 25 deaths per 1,000, an estimated 2.6 (2.3–2.8) million deaths of children under 5 would have been averted in 2017.
Extended Data Fig. 2
Impact of inequality on U5MR.
a, Potential reduction in the number of deaths that would have occurred if all second administrative-level units in the 20 countries with the greatest number of deaths of children under 5 in 2017 realized a homogenous U5MR that was equal to that of the lowest observed mortality rate in that country. In total, 66% of under-5 deaths could have been averted if all countries maintained mortality rates equal to the second administrative-level unit with lowest mortality. If this reference rate is set to the lowest observed rate across all of the 99 countries that were included in this study, 95% of under-5 deaths could have been averted. The size of each bar represents the total number of under-5 deaths in each country. The red portion of each bar indicates the number of deaths ‘attributed’ to geographical inequality in mortality rates, whereas the blue portion represents the number of deaths that would remain in the scenario in which all second administrative-level units within countries had the same mortality rate as the best-performing unit. b, Locations of under-5 deaths ‘attributable’ to geographical inequality, across all second administrative-level units in each country. Each country has one unit highlighted with a green diamond, which is the reference unit, or the location with the lowest mortality rate in the country in 2017.
Discussion
This study offers a comprehensive, geospatially resolved resource for national and subnational estimates of child deaths and mortality rates for 99 LMICs, where 93% of the world’s child deaths[4] occurred in 2017. Gains in child survival varied substantially within the vast majority of countries from 2000 to 2017. Countries such as Vietnam, for example, showed more than fivefold variation in mortality rates across second administrative-level units. The inconsistency of successes, even at subnational levels, indicates how differences in health policy, financial resources, access to and use of health services, infrastructure, and economic development ultimately contribute to millions of lives cut short[25-27]. By providing detailed maps that show precisely where these deaths are estimated to have occurred, we provide an important evidence base for looking both to the past, for examples of success, and towards the future, in order to identify where precision public-health initiatives could save the most lives.The epidemiological toll of child mortality should be considered both in terms of total deaths and as rates of mortality. Focusing only on mortality rates can effectively mask areas in which rates are comparatively low but child deaths are high owing to large population sizes. The number of deaths that occur in high-risk areas has declined, and most under-5 deaths in recent years have occurred in lower-risk areas. This ‘prevention paradox’[28] could indicate that whole-population interventions could have a larger overall impact than targeting high-risk areas[29]. At the same time, strategies that target resources to those locations that have the highest number of child deaths risk leaving behind some of the world’s most marginalized communities: remote, more-sparsely populated places in which, relative to the number of children born each year, a large number of children die before their fifth birthday. Instead, by considering subnational measures of both counts and rates of deaths of children under 5, decision-makers can better tailor child health programs to align with local contexts, norms and needs. Rural communities with high rates but low counts may benefit from ‘last-mile’ initiatives to provide effective health services to populations who lack adequate access to care. By contrast, locations with low rates but high counts may require programs that focus on alleviating the cost of care, unsafe environmental exposures or health risks that are uniquely associated with urban slums[30]. The SDGs have pointed the global development agenda towards progress in child survival. Our analysis indicates that reaching the SDG 3.2 targets of 25 child deaths per 1,000 live births and 12 neonatal deaths per 1,000 live births will require only modest improvements or have already been achieved by some units; however, these targets are ambitious for other units in which child mortality remains high. It is worth noting that many countries contain areas that fit both of these profiles. For example, 11 countries had at least 1 unit that had already met SDG 3.2 with high certainty, and at least 1 unit that had not. Subnational estimates can empower countries to benchmark gains in child survival against their own subnational exemplars as well as advances that have been achieved by their peers. Through our counterfactual analysis we showed that even if all units had met the SDG 3.2 goal in 2017, there would still have been 2.4 million deaths of children under 5, indicating that ‘ending preventable child deaths’ is more complex than simply meeting a target threshold. Future research efforts must address the causes of child mortality in local areas and more precisely identify causes of child deaths that are amenable to intervention. To that end, new and innovative data-collection efforts, such as the ongoing Child Health and Mortality Prevention Surveillance network, offer promising prospects by applying high-validity, pathology-based methods alongside verbal autopsies to determine the cause of death[31].This study offers a unique platform to support the identification of local success stories that could be replicated elsewhere. In Rwanda, for example, the highest U5MR at the district level in 2017 was 60.2% (52.0–67.8%) lower than the lowest U5MR at the district level in 2000. Such gains have been partially credited to focused investments in the country’s poorest populations, expanding the Mutuelles de santé insurance program, and developing a strong workforce of community health workers who provide evidence-based treatment and health promotion[32,33]. Nepal and Cambodia are among the exemplars for considerably decreasing subnational inequalities in child survival since 2000. In an era when narrowing disparities within countries is as important as reducing national-level gaps, these results provide the evidence base to inform best practices and stimulate national conversations about related social determinants.Neonatal mortality rates have also declined but failed to keep pace with reductions in mortality rates of older children, leading to a higher proportion of deaths of children under 5 occurring within the first four weeks of life: from 37.4% (37.1–37.7) in 2000 to 43.7% (43.1–44.3%) in 2017. This trend is probably related to the increase in scale of routine programs and improved infrastructure (for example, vaccination[34], and water and sanitation[35]) and the introduction of effective interventions to target communicable diseases (for example, malaria control[36] and prevention of mother-to-child transmission of HIV[37]). These interventions have tended to target amenable causes of mortality that are more common in older children under 5 rather than dominant causes of neonatal mortality, such as prematurity and congenital anomalies[38]. Notably, irrespective of income level or location, some causes of neonatal death (for example, chromosomal anomalies and severe preterm birth complications) remain difficult to prevent completely with current medical technologies. Ultimately, large gains in neonatal mortality will require serious investment in health system strengthening[39]. Affordable approaches to preventing the majority of neonatal deaths in LMICs exist and there are success stories with lessons learned to apply[40-44], but decisions about which approaches to take must be based on the local epidemiological and health system context. In the absence of spatially detailed cause of death data, subnational neonatal mortality estimates can indicate dominant causes and thus serve as a useful proxy to guide prioritization of interventions[45].The accuracy and precision of our estimates were primarily determined by the timeliness, quantity and quality of available data. In Sri Lanka, for example, there were no available surveys, and the wide uncertainty intervals surrounding estimates reflect the dearth of available evidence in that country (Extended Data Figs. 3, 4). In certain areas, this decreased the confidence that we had in claiming that a specific subnational area met the SDG 3.2 target (Fig. 1c). This issue is most concerning in cases in which estimated mortality rates are high, thus helping to identify locations in which it would be most useful to focus future data-collection efforts. High mortality rates with large uncertainty intervals were estimated across much of Eastern and Central sub-Saharan Africa, and in Cambodia, Laos, Myanmar and Papua New Guinea (Extended Data Figs. 3, 4). Furthermore, ongoing conflict in countries such as Syria, Yemen and Iraq pose substantial challenges to collecting more contemporaneous data, and our estimates may not fully capture the effects of prolonged civil unrest or war[46,47]. Further methodological and data limitations are discussed in the Methods.
Extended Data Fig. 3
Relative uncertainty in U5MR estimates for 2017.
Relative uncertainty in second administrative-level estimates compared with mean estimated U5MRs in each second administrative-level unit for 2017. Mean rates and relative uncertainty are split into population-weighted quartiles. These cut-off points indicate the relative uncertainty minimum, 25th, 50th and 75th percentiles, and maximum, which are 0.29, 0.51, 0.63 and 0.86, and 3.12, respectively. The under-5 mortality minimum, 25th, 50th and 75th percentiles, and maximum are 1.4, 13.0, 22.9 and 44.8, and 190.6 deaths per 1,000 live births. Areas in which our estimates are more uncertain are coloured with a scale of increasing blue hue, whereas areas in which the mean estimates of U5MR are high are coloured with a scale of increasing red hue. Purple areas have high, but uncertain, estimates of U5MRs. White areas have low relative mortality, with fairly certain estimates. Relative uncertainty is defined as the ratio of the width of the 95% uncertainty interval to the mean estimate.
Extended Data Fig. 4
Lower and upper uncertainty interval boundaries for U5MR mortality estimates in 2017.
a, b, Lower (a) and upper (b) 95% uncertainty intervals for U5MR estimates across the second administrative-level units in 99 countries.
The accurate estimation of mortality is also a matter of equity; highly refined health surveillance is common in high-income countries, whereas in LMICs, in which rates of child mortality are the highest, surveillance that helps to guide investments in health towards the areas with the greatest need is less routine[48]. Ideally, all countries would have high-quality, continuous, and complete civil and vital registration systems that capture all of the births, deaths and causes of death at the appropriate geographical resolution[49]. In the meantime, analyses such as this serve to bridge the information gap that exists between low-mortality countries with strong information systems and countries that face a dual challenge of weaker information systems and higher disease burden.By harnessing the unprecedented availability of geo-referenced data and developing robust statistical methods, we provide a high-resolution atlas of child death counts and rates since 2000, covering countries that account for 93% of child deaths. We bring attention to subnational geographical inequalities in the distribution, rates and absolute counts of child deaths by age. These high-resolution estimates can help decision-makers to structure policy and program implementation and facilitate pathways to end preventable child deaths[50] by 2030.
Methods
Overview
We fitted a discrete hazards geostatistical model[51,52] with correlated space–time–age errors and made predictions to generate joint estimates—with uncertainty—of the probability of death (the number of deaths per live births) and the number of deaths for children aged 0–28 days (neonates), children under 1 year old (infants) and children under 5 years old at the subnational level for 99 LMICs for each year from 2000 to 2017. The analytical process is summarized in the flowchart in Extended Data Fig. 6. We made estimates at a grid-cell resolution of approximately 5 × 5-km and then produced spatially aggregated estimates at the first (that is, states or provinces) and second (that is, districts or counties) administrative levels, as well as the country level.
Extended Data Fig. 6
Flowchart summarizing analytical process.
Standard demographic notation were used. n, length of age bin; x, starting age of age bin; d, number of deaths; q, probability of death; a, average time lived in age bin by those who died in the age bin.
Countries were selected for inclusion in this study based on their socio-demographic index (SDI) published in the Global Burden of Disease study (GBD)[53]. The SDI is a measure of development based on income per capita, educational attainment and fertility rates among women under 25 years old. We primarily aimed to include all countries in the middle, low–middle or low SDI quintiles, with several exceptions. Brazil and Mexico were excluded despite middle SDI status owing to the availability of high-quality vital registration data in these countries, which have served as the basis for existing subnational estimates of child mortality. Because this study did not incorporate vital registration data sources (see ‘Limitations’), Brazil and Mexico were not estimated directly; instead, state-level estimates from the GBD 2017 study were directly substituted in figures where appropriate[4]. Albania and Moldova were excluded despite middle SDI status owing to geographical discontinuity with other included countries and lack of available survey data. North Korea was excluded despite low–middle SDI status owing to geographical discontinuity and insufficient data. As countries with high–middle SDI status in 2017, China and Malaysia were excluded from this analysis. Libya was included despite high–middle SDI status to create better geographical continuity. Island nations with populations under 1 million were excluded because they typically lacked sufficient survey data or geographical continuity for a geospatial analytic approach to be advantageous over a national approach. Supplementary Figure 3.1 shows a map of the countries included in this study and Supplementary Table 3.1 lists the countries.
Data
We extracted individual records from 555 household sample survey and census sources. Records came in the form of either summary birth histories (SBHs) or complete birth histories (CBHs). All input data were subject to quality checks, which resulted in the exclusion of 82 surveys and censuses owing to quality concerns (see Supplementary Information section 3.2 for more details). Data on life and mortality experiences from CBH sources can be tabulated directly into discrete period and age bins, thus allowing for period-specific mortality estimations, known as the synthetic cohort method[54-56]. For SBH data, we used indirect estimation[57] to estimate age-specific mortality probabilities and sample sizes and assign them to specific time periods. Complete details are available in Supplementary Information section 3.3.2.In all cases, after pre-processing, each data point provided a number of deaths and a sample size for an age bin in a specific year and location. We referenced all data points to GPS coordinates (latitude and longitude) wherever possible. In cases in which GPS data were unavailable, we matched data points to the smallest possible areal unit (also referred to as ‘polygons’). All polygon data were spatially resampled into multiple GPS coordinates and weighted based on the population distribution following a previously described procedure[5,22,23,58] and described in Supplementary Information section 3.4. Our combined global dataset contained approximately 15.9 million births and 1.1 million child deaths. A complete list of data sources is provided in Supplementary Table 8.1.In addition to data on child mortality, we used a number of spatial data sources for this analysis. These included a suite of geospatial covariates, population estimates and administrative boundaries[68]. These sources and processing procedures are described in Supplementary Information section 4.
Spatial covariates
We extracted values from each of 10 geospatial covariates at each data point location. Geospatial covariates are spatial data represented at the 5 × 5-km grid-cell resolution. The covariates were travel time to the nearest city, educational attainment of maternal-aged women, the ratio of population of children under 5 to women of reproductive age (ages 15–49 years old), the mass per cubic meter of air of particles with a diameter less than 2.5 μm, total population, a binary indicator of urbanicity, intensity of lights at night, the proportion of children aged 12–23 months who had received the third dose of diphtheria–pertussis–tetanus vaccine, incidence rate of Plasmodium falciparum-associated malaria in children under 5 and prevalence of stunting in children under 5 (see Supplementary Information). All covariate values were centred on their means and scaled by their standard deviations. Covariates typically had global spatial coverage and values that vary by year. More details of the spatial covariates can be found in Supplementary Information section 4.
Analysis
Geostatistical model
To synthesize information across various sources, and to make consistent estimates across space and time, we fitted discrete hazards[51,52] geostatistical models[59] to our data. The models were discrete in the sense that ages were represented in seven mutually exclusive bins (0, 1–5, 6–11, 12–23, 24–35, 36–47 and 48–59 months), each with its own assumed constant mortality probability. The model explicitly accounted for variation across age bin, year and space through inclusion of both fixed and random effects. Indicator variables for each age bin were included to form a discrete baseline mortality hazard function, representing the risk of mortality in discrete bins from birth to 59 months of age with covariates set at their means. Baseline hazard functions were allowed to vary in space and time in response to changing covariate values, as well as in response to linear effect on year. To model this relationship, we estimated the effect of each covariate value on the risk of mortality. These estimated effects were then applied to the gridded surface of covariate values to make predictions across the entire study geography. We also included a Gaussian random effect across countries to account for larger-scale variations due to political or institutional effects, as well as a Gaussian random effect for each data source to account for source-specific biases. Finally, we included a Gaussian process random effect with a covariance matrix structured to account for remaining correlation across age, time and physical space. As such, estimates at a specific age, time or place benefitted from drawing predictive strength from data points nearby in all of these dimensions.For each modelling region, we fitted one such discrete hazards model with a binomial data likelihood. All data were prepared such that we counted or estimated the number of children entering into (n) and dying within (Y) each period–age bin from each GPS-point location (s) in each survey (k) within each country (c).The number of deaths for children in age band (a) in year (t) at location (s) was assumed to follow a binomial distribution:where P is the probability of death in age bin a, conditional on survival to that age bin for a particular space–time location. Using a generalized linear regression modelling framework, a logit link function is used to relate P to a linear combination of effects:The first term, β0, is an intercept, representing the mean for the first age band when all covariates are equal to zero, whereas are fixed effects for each age band, representing the mean overall hazard deviation for each age band from the intercept, when all other covariates are equal to zero. β2 are the effects of geospatial covariates (X), which we describe in detail in Supplementary Information section 4. β3 is an overall linear temporal effect to account for overall temporal trends within the region. All geospatial covariates were centred and scaled by subtracting their mean and dividing by their standard deviations. Each v term represents uncorrelated Gaussian random effects: is a country-level random effect applied to all locations (s) within a country (c); is a data source-level random effect for the survey (k) from which the data at location s were observed. Data source-level random effects were used to account for systematic variation or biases across data sources and were included in model fitting but not in prediction from fitted models. The term Z ~ Gaussian process(0, K) is a correlated random effect across age, space and time, and is modelled as a four-dimensional mean zero Gaussian process with covariance matrix K. This term accounts for structured residual correlation across these spatial–age–temporal dimensions that are not accounted for by any of the model’s other fixed or random effects. This structure was chosen, because the hazard probability for each age group is expected to vary in space and time, and such spatiotemporal correlations are likely to be similar across ages. K is constructed as a separable process across age, space and time . The continuous spatial component is modelled with a stationary isotropic Matérn covariance function, and the age and temporal effects were each assumed to be discrete auto-regressive order 1. We provide further details on model fitting and specification in Supplementary Information section 5.1.We assigned priors to all model parameters and performed maximum a posteriori inference using Template Model Builder[60] software in R version 3.4. We fitted the model separately for each of 11 world regions (see Supplementary Fig. 3.1), owing to memory constraints and to allow model parameters to vary across epidemiologically distinct regions.
Post-estimation
Using the joint precision matrix and point estimates, we generated 1,000 draws from all model parameters using a multivariate-normal approximation. These model parameter draws were used to predict corresponding draws of mortality probabilities across all age groups for each grid cell in each year. In other words, for each age bin in each year we estimated 1,000 gridded surfaces of mortality probability estimates, each surface corresponding to one draw from the posterior parameter estimates[61]. All subsequent post-estimation procedures were carried out across draws to propagate model uncertainty. We used these estimated spatiotemporal gridded surfaces of age-specific mortality probabilities to produce various final resulting data products.From the fitted model parameters, we produced posterior mortality probability estimates for each age group for each 5 × 5-km grid cell for each year from 2000 to 2017. We combined gridded age group estimates to obtain infant (under 1) and child (under 5) mortality estimates at each gridded location. Using a conversion from mortality probability to mortality rates, and using a gridded surface of population, we also estimated the number of deaths that occurred in each age group at each location in each year. For both mortality probabilities and counts, we multiplied out corresponding gridded estimates by a constant to ensure that at the national—and in two countries, the first administrative-level unit—aggregated estimates for each age group and year were calibrated such that they equalled estimates in the GBD study[4]. This calibration allowed us to take advantage of national data sources, such as vital registration, that could not be used in this study. We also aggregated grid-cell-level estimates to first and second administrative-level units using gridded population surface to weight estimates. These steps are described in Supplementary Information section 5.2.
Model validation
We used fivefold cross-validation to assess and compare model performance with respect to estimating local trends of age-specific mortality. Each fold was created by combining complete surveys into subsets of approximately 20% of data sources from the input data. Holding out entire surveys at a time served as a comparable approximation to the type of missingness in our data, essentially helping us check how well our model estimates of mortality probabilities compared to empirical estimates of mortality probability from an unobserved data source that did not inform the model.For each posterior draw, we aggregated to administrative units. Using data aggregated to the administrative unit and aggregated estimate pairs, we calculated the difference between out-of-sample empirical data estimates and modelled estimates, and we report the following summary metrics: mean error, which serves as a measure of bias, the square root of mean errors, which serves as a measure of the total variation in the errors, the correlation and 95% coverage. At the second administrative-level unit for under-5 mortality, our out-of-sample 95% coverage was 93%, correlation was 0.78, mean absolute error was 0.015 and mean error was −0.0011. These results indicate a good overall fit, with minimal bias. This procedure and the full validation results are discussed in Supplementary Information section 5.3.
Limitations
This work should be assessed in full acknowledgement of several data and methodological limitations. We exclusively used CBH and SBH data from household survey and census data sources. Ideally, estimates of child mortality should incorporate all available data, including data from administrative vital registration systems. Vital registration systems are commonly present in many middle-income and all high-income countries. There are known data-quality issues with vital registration sources in many middle-income countries[48,62] that add complications to their inclusion in our modelling procedure. For example, systems may not capture all deaths, and this level of ‘underreporting’ probably varies in space, time and age. In addition, underreporting is probably negatively correlated with mortality, and could contribute substantial bias to estimates. Statistical methods must be developed to jointly estimate—and adjust for—underreporting in vital registration data before such data can be used in geospatial models of child mortality. Promising work has begun in this domain in specific countries[63], but further advancement will be necessary to improve estimates across a time series and across many countries at once.We assume that SBH and CBH data were retrospectively representative in the locations in which they were collected. As such, we assume that survey respondents did not migrate. High-spatial-resolution migration estimates with which to adjust estimates do not yet exist, and many of the data sources that we use do not collect information on migration. We conducted a focused sensitivity analysis (Supplementary Information section 5.4.4) for migration in six countries, and found that although our results were generally robust, there was variation by country. Furthermore, despite providing high-quality retrospective data from representative samples of households, birth history data can suffer from certain non-sampling issues, such as survival/selection biases[64] and misplacement of births[65]. We did not attempt to make corrections to data, and they were used as-is. Furthermore, retrospective birth history data will—by design—have a changing composition of maternal ages depending on the time since the survey. This was minimized by limiting retrospective trends to up to 17 years.Although we collated a large geo-referenced database of survey data on child mortality, these data represented about 1% (1.1 million) of total deaths of children under 5 in study areas over the period. Where data do not exist or are not available in certain locations, mean estimates are informed from smoothing to nearby estimates and covariates. As such, there could be additional small-scale heterogeneity that is not picked up by our model. Wider uncertainty intervals in areas with no data account for these potential unknowns, and our 95% coverage estimates in out-of-sample predictive tests appear to be well-calibrated at the second administrative unit level. Furthermore, discrete localized mortality shock events could be missing in our analysis due to the lack of data and selection biases in surveys and censuses, and spatiotemporal smoothing. Fatal discontinuities are explicitly accounted for at the national or province level by calibration to GBD estimates. In all, 0.35% (0.4 million) of the 123 million deaths over this period were attributed to fatal discontinuities.On the modelling side, we integrated point and areal data into a continuous model by constructing pseudo-points from areal data. Modelling approaches that integrate point and areal data as part of a joint model likelihood function are in development[66] but are currently computationally infeasible at the large geographical scales at which we currently model. Furthermore, we divided our models into 11 regional fits (see Supplementary Fig. 3.1), as a full model that encompasses all 99 countries would be computationally infeasible due to memory constraints. Splitting up modelling in this way had the benefit of enabling parameters to vary across epidemiologically distinct world regions. A preferred model, however, would be fitted to all data simultaneously with parameters that are spatially variable.The separable model used for age–space–time correlations is a common parsimonious assumption afforded in applying spatiotemporal geostatistical models due to efficient computation and inference; however, it yields the assumption of fully symmetric covariance. The symmetry implicit in the separable model dictates, for example, that (holding age constant for simplicity) the covariance between the observations at (location 1, time 1) and (location 2, time 2) is the same as the covariance between (location 1, time 2) and (location 2, time 1). Given our available data density in space–age–time, we believe that attempting to parameterize a more complex non-separable model would be challenging both computationally and inferentially, and it is not clear whether there would be much to benefit from the extra complications.There are several limitations to address with respect to the use of covariates in the model. Most of the geospatial covariates that we used in the geostatistical model were themselves estimates produced from various geospatial models. Some of those estimated surfaces used covariates that were also included in our model in their estimation process. As such, we emphasize that our model is meant to be predictive, and that drawing inference from fitted coefficients across these highly correlated covariates is problematic and not recommended. Furthermore, we assumed no measurement error in the covariate values and assumed that the functional form between mortality and all covariates was linear in logit space. In certain locations, we used covariate values for prediction that were outside the observed range of the training data. As we explore in Supplementary Information section 5.4.2, however, these areas represent a relatively small proportion of the population.Finally, we used a method for indirect estimation of SBHs that was recently developed and validated[57]. As such, indirect estimation was carried out as a pre-processing step before fitting the geostatistical model. We attempted to propagate various forms of uncertainty that could be introduced in this step, which resulted in halving the total effective sample size across all SBH data. In future, we aim to fully integrate such processing into the statistical model; such methods are in development[67], but are not yet computationally feasible at scale.
Authors: Laura Dwyer-Lindgren; Frank Kakungu; Peter Hangoma; Marie Ng; Haidong Wang; Abraham D Flaxman; Felix Masiye; Emmanuela Gakidou Journal: Spat Spatiotemporal Epidemiol Date: 2014-10-13
Authors: Jon Wakefield; Geir-Arne Fuglstad; Andrea Riebler; Jessica Godwin; Katie Wilson; Samuel J Clark Journal: Stat Methods Med Res Date: 2018-04-19 Impact factor: 3.021
Authors: Nick Golding; Roy Burstein; Joshua Longbottom; Annie J Browne; Nancy Fullman; Aaron Osgood-Zimmerman; Lucas Earl; Samir Bhatt; Ewan Cameron; Daniel C Casey; Laura Dwyer-Lindgren; Tamer H Farag; Abraham D Flaxman; Maya S Fraser; Peter W Gething; Harry S Gibson; Nicholas Graetz; L Kendall Krause; Xie Rachel Kulikoff; Stephen S Lim; Bonnie Mappin; Chloe Morozoff; Robert C Reiner; Amber Sligar; David L Smith; Haidong Wang; Daniel J Weiss; Christopher J L Murray; Catherine L Moyes; Simon I Hay Journal: Lancet Date: 2017-09-25 Impact factor: 79.321
Authors: Peter M Macharia; Emanuele Giorgi; Pamela N Thuranira; Noel K Joseph; Benn Sartorius; Robert W Snow; Emelda A Okiro Journal: BMC Public Health Date: 2019-02-04 Impact factor: 3.295
Authors: Laura Dwyer-Lindgren; Ellen R Squires; Stephanie Teeple; Gloria Ikilezi; D Allen Roberts; Danny V Colombara; Sarah Katherine Allen; Stanley M Kamande; Nicholas Graetz; Abraham D Flaxman; Charbel El Bcheraoui; Kristjana Asbjornsdottir; Gilbert Asiimwe; Ângelo Augusto; Orvalho Augusto; Baltazar Chilundo; Caroline De Schacht; Sarah Gimbel; Carol Kamya; Faith Namugaya; Felix Masiye; Cremildo Mauieia; Yodé Miangotar; Honoré Mimche; Acácio Sabonete; Haribondhu Sarma; Kenneth Sherr; Moses Simuyemba; Aaron Chisha Sinyangwe; Jasim Uddin; Bradley H Wagenaar; Stephen S Lim Journal: Popul Health Metr Date: 2018-08-13
Authors: Alexandra Heath-Freudenthal; Lilian Toledo-Jaldin; Inge von Alvensleben; Litzi Lazo-Vega; Rodrigo Mizutani; Margaret Stalker; Hussna Yasini; Fanny Mendizabal; Jesus Dorado Madera; William Mundo; Melany Castro-Monrroy; Julie A Houck; Any Moreno-Aramayo; Valquiria Miranda-Garrido; Emily J Su; Dino A Giussani; Steven H Abman; Lorna G Moore; Colleen G Julian Journal: Hypertension Date: 2022-04-19 Impact factor: 10.190